tyrosine and Cardiovascular Stroke

tyrosine has been researched along with Cardiovascular Stroke in 458 studies

Research

Studies (458)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (1.09)	18.7374
1990's	39 (8.52)	18.2507
2000's	258 (56.33)	29.6817
2010's	148 (32.31)	24.3611
2020's	8 (1.75)	2.80

Authors

Authors	Studies
Gaidukova, KA; Gurova, NA; Khaliullin, FA; Kucheryavenko, AF; Pavlov, VN; Samorodov, AV; Sirotenko, VS; Spasov, AA	1
Chidangil, S; Devasia, T; John, RV; Lukose, J; N, M	1
Li, R; Tang, X; Zhang, T	1
Jiang, Y; Liu, X; Tan, Y; Wang, B; Yang, J; Zhan, Z; Zhou, W	1
Bäckhed, F; Buffa, JA; Demuth, I; Fischbach, MA; Haghikia, A; Hazen, SL; König, M; Landmesser, U; Li, L; Li, XS; Nemet, I; Romano, KA; Steinhagen-Thiessen, E; Tang, WHW; Wilcox, J; Witkowski, M	1
Akhdar, A; Armstrong, J; Ebenhoch, R; Frego, L; Gupta, P; Huang, Y; Korf-Klingebiel, M; Miglietta, J; Nar, H; Pekcec, A; Reboll, MR; Rybina, I; Wollert, KC	1
Degrauwe, S; Iglesias, JF; Laurencet, ME; Noble, S; Tessitore, E	1
Allgeyer, E; Amrute-Nayak, M; Chen, X; Chenoweth, H; Clement, M; Doreth, C; Harrison, J; Huang, H; Johnston, DS; Krieg, T; Li, X; Mallat, Z; Sirinakis, G; Tokuraku, K; Yu, X; Zhao, A; Zhou, H	1
Akhtari, S; Chandran, V; Colaco, K; Cook, RJ; Eder, L; Gladman, DD; Harvey, P; Lee, KA; McInnes, IB; Piguet, V; Sattar, N; Welsh, P; Winer, R	1
Andreadou, I; Bibli, SI; Brouckaert, P; Fisslthaler, B; Fleming, I; Papapetropoulos, A; Szabo, C; Zhou, Z; Zukunft, S	1
Li, J; Sun, H; Wu, X; Zhou, X	1
Adina, Q; Bildirici, U; Celikyurt, U; Dervis, E; Ural, D; Yavuz, S	1
Dager, WE; Walker, EA	1
An, Y; Guo, JJ; Hu, LG; Li, J; Li, YH; Liu, X; Wang, XF; Xu, FQ	1
Barbieri, L; De Luca, G; Nardin, M; Negro, F; Pergolini, P; Rolla, R; Suryapranata, H; Verdoia, M	1
Al-Awar, A; Berkó, AM; Börzsei, D; Juhász, B; Karácsonyi, Z; Kupai, K; Pósa, A; Szabó, R; Takács, I; Török, S; Varga, C	1
Chang, ST; Chu, CM; Chung, CM; Hsiao, JF; Hsu, JT; Lin, YS; Pan, KL; Yang, YT	1
Gao, D; Hu, S; Li, H; Li, M; Wang, H; Zhang, H; Zhu, J	1
Babu, A; Bedi, K; Bogush, AI; Caporizzo, MA; Chen, CY; Heffler, JG; Kelly, NA; Margulies, KB; Morley, MP; Prosser, BL; Robison, P; Salomon, AK; Vite, A	1
Chang, NC; Lee, TM; Lin, SZ	1
Huhn, R; Mayer, F; Ritz-Timme, S; Scholl, K	1
Auton, M; Brehm, MA; Denis, CV; Hellermann, N; Huck, V; Klemm, U; März, W; Obser, T; Schneider, SW; Schneppenheim, R; Tischer, A; Wilmanns, M; Xu, ER; Zotz, RB	1
Chen, Q; Deng, R; Gao, Z; Li, Z; Liu, Q; Liu, Y; Peng, X; Xiao, Q; Yu, F; Zhang, Y	1
Bellomo, G; Camaro, C; De Luca, G; Di Giovine, G; Marino, P; Pergolini, P; Restifo, M; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M	1
Ding, FH; DU, R; Hu, J; Qiu, JP; Shen, WF; Yang, ZK; Zhang, JS; Zhang, Q; Zhang, RY; Zhu, TQ	1
Abad, E; Garcia-Dorado, D; Hernando, V; Inserte, J; Poncelas-Nozal, M; Vilardosa, Ú	1
Gao, YX; Li, L; Li, Y; Sun, TW; Yu, XZ; Yuan, YQ; Zhao, XY	1
Abd El Motteleb, DM; Elshazly, SM; Nassar, NN	1
Hagiri, S; Hataishi, R; Hirose, M; Kobayashi, H; Kokubo, K; Sato, Y; Shinbo, T	1
Guo, M; Jia, Z; Liang, HQ; Song, Y; Zhang, YQ	1
Altay, S; Golcuk, Y; Gunay, E; Terzi, S; Velibey, Y; Yesilcimen, K	1
Feihl, F; Li, J; Liaudet, L; Loukili, N; Pacher, P; Rosenblatt-Velin, N; Waeber, B	1
Atalay, M; Isilak, Z; Kardesoglu, E; Uz, O; Yalçin, M	1
Liu, XH; Qu, Y; Shen, H; Xia, JG	1
Chen, Y; Chi, Y; Liu, C; Song, L; Wang, J; Wang, S; Yan, H; Zhao, B; Zhao, H; Zhou, P	1
El-Jack, S	1
Irwin, MG; Mei, B; Wang, T; Wang, Y; Wong, GT; Xia, Z	1
Dong, P; Li, Z; Liu, X; Wang, H; Wang, S; Xing, S; Yang, X; Zhai, Q; Zhang, H	1
Ding, FH; Hu, J; Jiang, L; Jin, HG; Lu, L; Qiu, JP; Shen, WF; Shen, Y; Yang, ZK; Zhang, Q; Zhang, RY; Zhu, TQ	1
Chen, C; Cheung, CW; Irwin, MG; Li, H; Liu, Z; Wang, J; Wong, GT; Xia, Z; Zhang, L	1
Xie, Q; Zhang, J; Zhang, T; Zhu, J	1
Chen, M; Li, FO; Li, Q; Miao, GB; Tong, ZC; Wei, Y; Zhang, JJ; Zhao, H	1
Anghelina, M; Butt, OI; Moldovan, L; Moldovan, NI; Varadharaj, S; Wang, T; Yang, F; Zweier, JL	1
Asanin, M; Brdar, N; Djuricic, N; Krljanac, G; Lasica, R; Marinkovic, J; Mrdovic, I; Perunicic, J; Savic, L	1
Li, L; Liu, Y; Su, Q	1
Du, J; Li, W; Liu, Y; Ni, Z; Wang, H; Wang, L; Xia, K; Xu, L; Yang, X; Zhang, D	1
Arif Yalcin, A; Biyik, I; Celik, O; Erturk, M; Faruk Akturk, I; Murat Caglar, I; Oner, E; Sarikamis, C; Turhan Caglar, N; Uzun, F	1
Acikel, M; Aksakal, E; Bakirci, EM; Karal, H; Kaya, A; Kurt, M; Sevimli, S; Tanboga, IH; Topcu, S	1
Li, W; Liu, Y; Ni, Z; Wang, H; Wang, L; Xia, K; Xu, L; Yang, X; Zhang, D	1
Mayer, F; Pröpper, S; Ritz-Timme, S	1
Austin, D; Christie, J; de Belder, MA; Hennigan, B; Mackay, DF; Morley, R; Oldroyd, KG; Pell, JP	1
Gao, C; Hu, D; Li, M; Liu, H; Wang, X; Yang, H; Zhang, Y; Zhu, Z	1
Brener, SJ; Sattur, S; Stone, GW	1
Akpek, M; Arinc, H; Baktir, AO; Ergin, A; Kaya, MG; Oguzhan, A; Saglam, H; Sahin, O; Sarli, B; Urkmez, S	1
Cao, Z; Du, X; Hu, S; Wang, D; Wang, K; Zhang, C; Zheng, L; Zuo, G	1
Agostoni, P; Stella, PR; Timmers, L	1
Francis, PK; Gupta, PN; Shylaja, SV; Thomas, J	1
Adiyaman, A; Giannitsis, E; Hamm, C; Hoorntje, JC; Schellings, DA; Suryapranata, H; Ten Berg, JM; Van't Hof, AW	1
Dong, PS; Han, YH; Lai, LH; Wang, HL; Xing, SY; Zhao, JF; Zhu, JH	1
Bonomo, C; Cezar, MD; Damatto, RL; Fernandes, DC; Guizoni, DM; Junior, SA; Laurindo, FR; Lima, AR; Martinez, PF; Matsubara, LS; Novelli, EL; Okoshi, K; Okoshi, MP; Pagan, LU; Seiva, FR; Zornoff, LA	1
Ding, FH; Du, R; Hu, J; Liao, ML; Shen, WF; Wang, XL; Yang, ZK; Zhang, JS; Zhang, Q; Zhang, RY; Zhu, TQ	1
Adiyaman, A; Beukema, R; Elvan, A; Gal, P; Parlak, E; Schellings, DA; ten Berg, J; van 't Hof, AW	1
Cavender, MA; Faxon, DP	1
Chen, J; Chen, S; Guo, J; Han, Y; Jiang, D; Jiang, T; Jing, Q; Li, J; Li, Y; Liang, Z; Liu, H; Stone, GW; Su, X; Wang, Y; Xu, B; Yang, P; Zang, H; Zhao, X; Zheng, Y	1
Can, MM; Demircan, HC; Esen, AM; İzgi, İA; Kaymaz, C; Keleş, N; Kırma, C; Koca, F; Özdemir, N; Özkan, A; Tanboğa, İH; Türkmen, M	1
He, Y; Huang, WG; Li, B; Luo, JY; Wang, LX; Wang, SX; Wu, TG; Xu, YJ; Zhao, Q	1
Gorog, DA; Jeong, YH; Kim, JS	1
Han, Y; Li, Y; Stone, GW	1
He, Y; Jin, J; Li, J; Qian, D; Yu, S	1
Baranyai, T; Ferdinandy, P; Giricz, Z; Károlyi-Szabó, M; Koncsos, G; Makkos, A; Nagy, CT; Onódi, Z; Varga, ZV	1
Han, Y; Li, Y; Liang, Z; Liu, H; Ma, L; Stone, GW; Wang, D; Wang, J; Wang, S; Yang, L	1
Huang, H; Ouyang, F; Peng, H; Yin, Y; Zeng, J; Zhou, X	1
Huang, H; Sun, Z; Zeng, J	1
Chalouhi, N; Daou, B; Hasan, DM; Jabbour, P; Starke, RM	1
Li, WM; Liu, Y; Ni, ZH; Wang, HS; Wang, LF; Xia, K; Xu, L; Yang, XC; Zhang, DP	1
Bongetta, D; Gaetani, P; Lafe, E; Melazzini, F; Zappoli Thyrion, F; Zoia, C	1
Behmenburg, F; Falk, M; Huhn, R; Mayer, F; Ritz-Timme, S	1
Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD	1
Abreu-Gonzalez, P; Avanzas, P; Conesa-Zamora, P; Consuegra-Sanchez, L; Dominguez-Rodriguez, A; Sanchez-Grande, A	1
Badran, AV; Barbosa, R; Figueiredo, GL; Haddad, JL; Lago, IM; Lima, MO; Marin, JA; Novaes, GC; Pavão, RB; Schmidt, A	1
Absi, T; Chepurko, E; Galindo, CL; Gumina, RJ; Harrell, FE; He, H; Huttinger, R; Kohr, MJ; Novitskaya, T; Roden, DM; Shaffer, CM; Song, Y; Su, YR; Varadharaj, S; Wells, QS; Wheeler, DG; Xu, M; Xu, Z; Zhang, B; Ziolo, MT; Zweier, JL	1
Angiolillo, DJ; Campo, G; Colangelo, S; de Cesare, N; Ferrari, F; Ferrari, R; Furgieri, A; Hamon, M; Kubbajeh, M; Meliga, E; Parrinello, G; Percoco, G; Repetto, A; Sabatè, M; Tumscitz, C; Valgimigli, M; Vranckx, P	1
Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH	1
Montalescot, G	2
Dambrink, JH; Dill, T; Funck, RC; Giannitsis, E; Hamm, C; Heestermans, T; Ottervanger, JP; Stella, P; Suryapranata, H; Ten Berg, J; van Houwelingen, G; van Werkum, W; Van't Hof, AW	1
Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Shiomi, M; Tsujioka, A; Tsujioka, H; Yoshida, K	1
Banerjee, S; Blazing, MA; Braunwald, E; Brilakis, ES; Califf, RM; Cannon, CP; de Lemos, JA; Morrow, DA; Murphy, SA; Sabatine, MS; Wiviott, SD	1
Iavelov, IS	1
Simsek, V; Timurkaynak, T; Turkoglu, S	1
Giannitsis, E; Ivandic, BT; Katus, HA; Keck, F; Kurz, K; Lehrke, S; Staritz, P	1
Binetti, N; Franco, N; Gordini, G; Guiducci, V; Magnavacchi, P; Manari, A; Marinucci, L; Marra, S; Marrozzini, C; Marzocchi, A; Piovaccari, G; Reggiani, ML; Saia, F; Sangiorgio, P; Taglieri, N	1
Bosković, A; Dragnić, S; Knezević, B; Musić, L; Nikolić, G	1
Andreadou, I; Antoniadis, A; Farmakis, D; Fountoulaki, K; Ikonomidis, I; Iliodromitis, EK; Kremastinos, DT; Leftheriotis, D; Paraskevaidis, IA	1
Cavusoglu, E; Lazar, J; Marmur, JD; Poludasu, S	1
Zijlstra, F	1
Valgimigli, M; van 't Hof, AW	1
Ottervanger, JP; Remijn, JA; Slingerland, RJ; Smit, JJ; van 't Hof, AW; van Oeveren, W; Zijlstra, F	1
Bildirici, U; Celikyurt, U; Ural, E	1
Biagini, E; Conrotto, F; Giacometti, P; Guiducci, V; Manari, A; Marrozzini, C; Marzocchi, A; Piovaccari, G; Reggiani, ML; Rocchi, G; Saia, F; Taglieri, N; Tondi, S	1
Kimura, S; Lu, XM; Matsuyoshi, H; Nishiyama, A; Shimizu, J; Takaki, M; Yu, YQ; Zhang, GX	1
Cassetti, E; De Luca, G; Marino, P; Ucci, G	1
Brener, SJ	1
Duran, NE; Kocabay, G; Ozkan, M; Yildiz, M	1
Angiolillo, DJ; Brugaletta, S; Campo, G; Colangelo, S; de Cesare, N; Ferrari, R; Furgieri, A; Hamon, M; Meliga, E; Parrinello, G; Percoco, G; Repetto, A; Sabatè, M; Valgimigli, M; Vranckx, P	1
Choe, YH; Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Kim, JH; Lee, SH; Lee, SY; Song, YB	1
Danzi, GB; Marzocchi, A	1
Merlini, PA; Valgimigli, M	1
Savonitto, S	1
De Boer, MJ; Dill, T; Gosselink, AT; Hamm, C; Heestermans, AA; Hoorntje, JC; Koopmans, PC; Ten Berg, JM; Van 't Hof, AW; Van Houwelingen, G; Van Werkum, JW	1
Chen, CM; Cheng, ML; Chiu, DT; Gu, PW; Ho, HY; Li, JM; Wang, YL	1
Csonka, C; Csont, T; Fekete, V; Ferdinandy, P; Kupai, K; Marais, de W; Odendaal, L; van Rooyen, J	1
Bhasin, A; Chai, HT; Chang, LT; Chen, CJ; Chen, SM; Chung, SY; Hang, CL; Hsieh, YK; Sun, CK; Wu, CJ; Yang, CH; Yip, HK; Youssef, AA	1
Briguori, C; Caccavale, M; D'Andrea, D; Focaccio, A; Golia, B; Librera, M; Ricciarelli, B; Tavano, D; Visconti, G	1
Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC	1
De Luca, G; Marino, P; Navarese, E	1
Avkiran, M; Bassi, R; Clark, JE; Jacquet, S; Kumphune, S; Marber, MS; O'Keefe, SJ; Sicard, P; Verma, S	1
Bates, ER; Chetcuti, S; Grossman, PM; Gurm, HS; Meier, P; Tamhane, U	1
Campo, G; Cangiano, E; Cavazza, C; Ferrari, R; Fileti, L; Frangione, A; Luccarelli, S; Valgimigli, M	1
Cai, X; Fu, F; Gao, F; Ji, L; Liu, W; Zhang, H; Zhang, L; Zheng, Q	1
Chen, CL; Chen, YR; Garg, V; Green-Church, KB; Hu, K; Kang, PT; Zhang, L	1
Jafary, FH; Rahman, N	1
Juwana, YB; Ottervanger, JP; Suryapranata, H; van 't Hof, AW	1
Gao, X; Ha, T; Hu, Y; Kao, RL; Kelley, J; Li, C; Liu, L; Lu, C; McMullen, JR; Williams, DL	1
Dong, L; Shu, X; Zhang, F	1
Chi, YP; Li, QX; Li, SY; Li, WZ; Song, L; Wang, J; Wu, Z; Yan, HB; Zhang, XJ; Zhao, HJ; Zheng, B	1
Armstrong, PW; Aylward, PE; Betriu, GA; Granger, CB; Holmes, DR; Huber, K; Montalescot, G; van 't Hof, AW; Westerhout, CM; Widimsky, P	1
Boersma, E; Dill, T; Hamm, C; Heestermans, T; Koopmans, PC; Mosterd, A; Stella, PR; ten Berg, JM; van 't Hof, AW; van Houwelingen, G; van Werkum, JW	1
Waksman, R	1
Catapano, O; De Vita, M; Galvani, M; La Vecchia, L; Ottani, F; Tarantino, F	1
Belle, L; Bonnefoy, E; Capel, O; Debaty, G; Dubien, PY; El Khoury, C; Mercier, C; Perret, T; Savary, D; Serre, P	1
Aytekin, V; Catakoğlu, AB; Demiroğlu, C; Erciyes, D; Erdim, R; Görmez, S; Gülbaran, M; Karabay, KO	1
Abbott, JD	1
Alonso, JJ; Alonso-Briales, JH; Ancillo, P; Bethencourt, A; Bosa, F; de Prado, AP; Fernández-Avilés, F; Gimeno, F; López-Messa, J; San Román, JA; Sánchez, PL; Sanchis, J; Santos, I; Sanz, JJ	1
Lin, X; Liu, Y; Ni, Z; Wan, X; Yang, X; Zhang, L; Zhang, Z	1
Dambrink, JH; Dill, T; Hamm, C; Heestermans, AA; Ottervanger, JP; Suryapranata, H; ten Berg, J; Timmer, JR; van 't Hof, AW; van Werkum, JW	1
Dill, T; Hamm, C; Heestermans, T; Ottervanger, JP; Slingerland, R; Smit, JJ; ten Berg, J; van 't Hof, AW; van Werkum, JW	1
Chen, ML; Fan, Q; Ge, YG; Irwin, MG; Liu, SH; Liu, Y; Wang, LF; Wang, W; Xia, Z; Yang, XC; Zhang, LK	1
Brugaletta, S; Campo, G; Colangelo, S; de Cesare, N; Ferrari, R; Fileti, L; Furgieri, A; Meliga, E; Russo, F; Valgimigli, M	1
Dill, T; Gosselink, AT; Hamm, C; Heestermans, AA; Hermanides, RS; Kolkman, JJ; Ottervanger, JP; Stella, PR; Ten Berg, JM; van 't Hof, AW; van Houwelingen, KG	1
Chen, LY; Hsin, HT; Liao, PC; Lin, PC; Wu, CF	1
Clerc, S; Feihl, F; Li, J; Liaudet, L; Loukili, N; Pacher, P; Rosenblatt-Velin, N; Waeber, B	1
Boersma, E; Dill, T; Gosselink, AT; Hamm, C; Heestermans, T; Kochman, W; Koopmans, PC; Mosterd, A; Stella, PR; ten Berg, JM; van 't Hof, AW; van Houwelingen, G; van Werkum, JW; van Zoelen, AB; Zijlstra, F	1
Blomeyer, C; Kehl, F; Lange, M; Lazariotto, M; Lotz, C; Pociej, J; Redel, A; Roewer, N; Schmidt, J; Smul, TM; Stumpner, J; Tischer-Zeitz, T	1
Chi, YP; Li, QX; Li, SY; Li, WZ; Liu, C; Song, L; Wang, J; Wu, Z; Yan, HB; Zhang, XJ; Zhao, HJ; Zheng, B	1
Dambrink, JH; Dill, T; Hamm, C; Hermanides, RS; Kolkman, E; Ottervanger, JP; Ten Berg, JM; van 't Hof, AW; van Houwelingen, G	1
Anselmi, M; Biondi-Zoccai, G; Boccuzzi, G; Bolognese, L; Campo, G; de Cesare, N; Díaz Fernández, JF; Ferrari, R; Malagutti, P; Moreno, R; Parrinello, G; Penzo, C; Ribichini, F; Rodriguez, AE; Russo, F; Valgimigli, M	1
Anselmi, M; Bolognese, L; Bressers, M; Bristot, L; Campo, G; Colangelo, S; De Cesare, N; Gambetti, S; Garcia-Garcia, HM; Garg, S; Monti, M; Moreno, R; Parrinello, G; Rodriguez, AE; Sarno, G; Serruys, PW; Valgimigli, M	1
Chen, CC; Hsu, YJ; Lee, TM	1
Bencsik, P; Boengler, K; Csont, T; Ferdinandy, P; Görbe, A; Kocsis, GF; Kupai, K; Schulz, R; Varga, ZV	1
Boes, L; Bonz, AW; Ertl, G; Lengenfelder, B; Stoerk, S; Strotmann, J; Voelker, W	1
Canga, Y; Durmuş, G; Ilhan, E; Karataş, MB; Kırbaş, V; Osmonov, D	1
Dündar, C; Erkol, A; Gibson, CM; İzgi, A; Kırma, C; Oduncu, V; Pala, S; Tigen, K	1
Chu, KM; Han, CL; Li, YH; Lin, GM	1
Moliterno, DJ	2
Cardenal, R; Diaz, JF; Gomez-Manchero, A; Sanchez-Gonzalez, C	1
Cakmak, M; Karabulut, A	1
Boersma, E; de Boer, MJ; Dill, T; Hamm, C; Hermanides, RS; Ottervanger, JP; Stella, PR; ten Berg, JM; van 't Hof, AW; van Houwelingen, G	1
Valgimigli, M	1
Dambrink, JH; de Boer, MJ; Gosselink, AT; Hamm, C; Heestermans, T; Koopmans, P; Mosterd, A; ten Berg, JM; van 't Hof, AW; van Houwelingen, G; van Werkum, JW; Zijlstra, F	1
Anastasiou-Nana, M; Andreadou, I; Dagres, N; Iliodromitis, EK; Kostidis, S; Kremastinos, DT; Mikros, E; Prokovas, E; Souridis, V; Tsantili-Kakoulidou, A; Zoga, A	1
Bolognese, L; Campo, G; Colangelo, S; de Cesare, N; Díaz Fernández, JF; Ferrari, R; Gambetti, S; Moreno, R; Nazzaro, MS; Parrinello, G; Penzo, C; Piva, T; Prati, F; Ribichini, F; Rodriguez, AE; Russo, F; Sheiban, I; Valgimigli, M; Vassanelli, C	1
Fujita, M; Iwasaka, T; Okazaki, T; Otani, H; Shimazu, T; Yoshioka, K	1
Hu, J; Jin, HG; Lu, L; Qiu, JP; Shen, J; Shen, WF; Yang, ZK; Zhang, Q; Zhang, RY; Zhao, LP; Zhu, TQ	1
Anna, F; Antonella, DS; Cappello, S; Di Stilo, A; Folino, A; Gianni, L; Losano, G; Pagliaro, P; Pasquale, P; Raffaella, R; Rastaldo, R; Sandra, C	1
Ge, YG; Li, WM; Ni, ZH; Wang, HS; Wang, LF; Xu, L; Yang, XC; Zhang, DP	1
Breet, NJ; Dambrink, JH; Gosselink, AT; Hamm, C; Hermanides, RS; Ottervanger, JP; ten Berg, JM; van 't Hof, AW; van Houwelingen, KG; van Werkum, JW	1
Bolognese, L; Bramucci, E; Campo, G; Colangelo, S; Corrada, E; De Cesare, N; E Rodriguez, A; Ferrante, G; Ferrari, R; Moreno, R; Nazzaro, MS; Pasquetto, G; Piva, T; Prati, F; Presbitero, P; Sheiban, I; Valgimigli, M; Vassanelli, C	1
Chilton, R	1
Candemir, B; Erol, C; Gerede, M; Kaya, CT; Kilickap, M; Kumbasar, D; Ozcan, OU; Ozdemir, AO; Ozdol, C	1
Batur, MK; Demirkol, S; Kurt, IH; Ünal, I	1
Allen, A; Armstrong, N; Di Nisio, M; Kleijnen, J; Lang, SH; Manning, N; Misso, K	1
Baroni, M; Musumeci, G; Rossini, R	1
Shen, WF	1
Dambrink, JH; Gosselink, AT; Hamm, C; Hermanides, RS; Ottervanger, JP; Stella, PR; ten Berg, JM; van 't Hof, AW; van Houwelingen, G	1
Banz, Y; Bovin, NV; Csizmadia, E; Gajanayake, T; Gordeeva, EA; Haeberli, A; Hess, OM; Korchagina, EY; Meier, P; Mettler, D; Rieben, R; Robson, SC	1
Guo, J; Xi, Y; Xu, M	1
Bristot, L; Campo, G; Ferrari, R; Gambetti, S; Monti, M; Parrinello, G; Tebaldi, M; Valgimigli, M	1
Steinhubl, SR	1
Ren, XN; Wang, LF; Wang, MS; Xu, L	1
Kern, MJ; Seto, A	1
Aksakal, E; Inci, S; Karakelleoğlu, S; Sevimli, S	1
Bellandi, F; Cutlip, D; De Luca, G; Dudek, D; Emre, A; Gabriel, HM; Gibson, CM; Gyongyosi, M; Huber, K; Maioli, M; Noc, M; Rakowski, T; Secco, GG; van 't Hof, AW; Zeymer, U; Zorman, S	1
Bayır, PT; Duyuler, S; Topaloğlu, S; Uygur, B	1
Chen, C; Peng, JJ; Ren, LH; Wang, ZY; Ye, HM	1
Fan, W; Fu, X; Geng, W; Gu, X; Hao, G; Jiang, Y; Li, S; Li, W; Wang, X; Wang, Y; Wu, W; Xue, H; Yang, Z; Zhao, Y	1
Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV	1
Coner, A; Müderrisoğlu, H; Okyay, K; Yıldırır, A	1
Brink, PR; Glass, PS; Liu, L; Rebecchi, MJ; Wang, Q; Zhu, J	1
Chen, B; Cui, Y; Huang, C; Ji, L; Li, R; Ma, L; Xing, W; Yu, J; Zhang, H; Zhang, W; Zhou, H	1
Berger, PB; Califf, RM; Chiswell, K; Hasselblad, V; Pieper, KS; Williams, JB	1
Bassand, JP	1
Califf, RM; Kandzari, DE	1
Fisher, EA; Kamran, M; Kini, AS; Lee, P; Marmur, JD; Perez, N; Richard, M; Sharma, SK; Suleman, J	1
Batchelor, WB; Califf, RM; Cantor, WJ; Davidian, M; DiBattiste, PM; Dillard, P; Gretler, D; Harrington, RA; Huang, Y; Larsen, RL; Mantell, RM; Ohman, EM; Sketch, MH; Tcheng, JE; Tolleson, TR; Zhang, D; Zidar, JP	1
Ardissino, D; Bassand, JP; Borzi, L; Demopoulos, LA; DiBattiste, PM; Harris, KA; Herrmann, HC; Macaya, C; Moliterno, DJ; Neumann, FJ; Stone, GW; Topol, EJ; Yakubov, SJ; Yeung, AC	1
Alpert, JS; Antman, EM; Beasley, JW; Braunwald, E; Califf, RM; Cheitlin, MD; Faxon, DP; Fuster, V; Gibbons, RJ; Gregoratos, G; Hiratzka, LF; Hochman, JS; Jacobs, AK; Jones, RH; Kereiakes, D; Kupersmith, J; Levin, TN; Pepine, CJ; Schaeffer, JW; Smith, EE; Smith, SC; Steward, DE; Theroux, P	1
Alexander, C; Becker, ER; Cannon, CP; Chu, H; Cook, JR; Culler, S; Demopoulos, LA; DiBattiste, PM; Jurkovitz, CT; Kosinski, AS; Mahoney, EM; Nag, S; Robertson, DH; Weintraub, WS	1
Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Glaser, R; Herrmann, HC; Murphy, SA	1
Ioannidis, JP; Karvouni, E; Katritsis, DG	1
DiBattiste, PM; Jang, Ik; Januzzi, JL; Sabatine, MS; Servoss, SJ; Theroux, P; Wan, Y	1
Boussaada, R; Chérif, A; Ezzar, T; Mechmèche, R; Messaoudi, H; Mourali, S	1
Antman, EM; Sabatine, MS	1
Maki, T; Nasa, Y; Takahashi, M; Takeo, S; Tanonaka, K	1
Carter, AJ; DiBattiste, PM; Fearon, WF; Herity, NA; Hiatt, BL; Huston, M; Lee, DP; Rezaee, M; Schreiber, D; Yeung, AC	1
Hobbach, HP; Schuster, P	1
Goto, S	1
Böhm, M; Fries, R	1
Foster, DA; McCollam, PL; Riesmeyer, JS	1
Bosnjak, ZJ; Camara, AK; Kampine, JP; Kevin, LG; Novalija, E; Stowe, DF	1
Dambrink, JH; de Boer, MJ; de Vries, ST; Gosselink, AT; Hoorntje, JC; Miedema, K; Suryapranata, H; van 't Hof, AW; Zijlstra, F	1
Auer, J; Berent, R; Eber, B; Lassnig, E; Maurer, E; Weber, T	1
Cakmak, M; Cam, N; Okmen, E; Tartan, Z	1
Chang, HW; Chen, MC; Chen, SM; Fang, CY; Hsieh, YK; Wu, CJ; Yip, HK	1
Abu-Shanab, JR; Dobesh, PP; Gowda, S; Haikal, MY; Lakamp, JE; Lanfear, SL	1
Casten, R; Dunkley, S; Evans, S; Jepson, N; Lindeman, R	1
Berger, PB; Bhatt, DL; Chan, AW; DiBattiste, PM; Moliterno, DJ; Sapp, SK; Stone, GW; Topol, EJ; Wolski, K; Yakubov, SL	1
Campbell, ME; Tcheng, JE	1
Caputo, RP; Carrozza, JP; Cutlip, DE; Dua, V; Garringer, J; Giri, S; Ling, FS; Ricciardi, MJ	1
Alemao, E; Bakhai, A; Ben-Joseph, R; Collinson, JR; Flather, MD; Itzler, R; Normand, C; Stevens, W	1
Bigonzi, F; Cohen, M; Danchin, N; Gensini, GF; Gurfinkel, EP; Hecquet, C; Huber, K; Krzeminska-Pakula, M; Maritz, F; Santopinto, J; Timerman, A; Vittori, L; White, HD	1
Herrmann, HC	1
Antman, EM; Bates, ER; Cohen, M; Every, NR; Ferguson, JJ; Harrington, RA; Pepine, CJ; Theroux, P	1
Huynh, T; Snapinn, S; Theroux, P; Wan, Y	1
Cohen, M; Gensini, GF; Gurfinkel, EP; Hecquet, C; Huber, K; Krzeminska-Pakula, M; Maritz, F; Santopinto, J; Timerman, A; Vittori, L	1
Merlini, PA; Rossi, ML	1
Aquilina, M; Branzi, A; Gaiba, W; Marrozzini, C; Marzocchi, A; Neri, S; Ortolani, P; Palmerini, T	1
Chang, HW; Chen, CJ; Chen, SM; Cheng, CI; Fang, CY; Hsieh, YK; Hung, WC; Wu, CJ; Yang, CH; Yip, HK	1
Baris, N; Duman, C; Ercan, E; Onbasili, OA; Tengiz, I	1
Adgey, AA; Manoharan, G	1
Harrington, RA; Nguyen, CM	1
Ben-Yehuda, O; DeMaria, AN; Kunichika, H; Kunichika, N; Lafitte, S; Peters, B	1
Dai, W; Kloner, RA	1
Berrino, L; Cuzzocrea, S; D'Amico, M; Di Filippo, C; Esposito, K; Giugliano, D; Marfella, R; Nappo, F; Piegari, E; Rossi, F	1
Antman, EM; Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Giugliano, RP; McCabe, CH; Morrow, DA; Murphy, SA; Sabatine, MS; Weintraub, WS	1
Carrillo, J; Delgado, L; García, H; Gaspar, J; Gaxiola, E; González, H; Leyva, JL; Lupi, E; Martínez-Ríos, MA; Martínez-Sánchez, C; Peña-Duque, MA; Rosas, M	1
Antman, EM; Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Gibson, CM; Giugliano, RP; McCabe, CH; Morrow, DA; Murphy, SA; Rifai, N; Sabatine, MS; Wiviott, SD	1
Abrams, CS; Cines, DB	1
Gill, DS; Ng, K; Ng, KS	1
Chai, HT; Chang, HW; Chen, CJ; Chen, MC; Chen, YH; Fu, M; Hang, CL; Wang, CP; Wu, CJ; Yeh, KH; Yip, HK; Yu, TH	1
Demir, M; Fareed, J; Gül, C; Iqbal, O; Kürüm, T; Ozbay, G; Vural, O	1
Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP	1
Duncker, DJ; Gho, BC; Gho, CC; Kazim, S; Liem, DA; Manintveld, OC; Verdouw, PD	1
DiBattiste, PM; Jang, IK; Januzzi, JL; Servoss, SJ; Snapinn, SM; Theroux, P; Wan, Y; Zhao, XQ	1
Carotenuto, R; Chieffo, C; Corsini, F; Corsini, G; Martone, A; Melorio, S; Romano, S; Schioppa, M; Sideri, F; Vetrano, A	1
De Caterina, R; Zimarino, M	1
Abdel-Aty, H; Al-Saadi, N; Friedrich, MG; Messroghli, DR; Schulz-Menger, J; Taylor, AJ	1
Büttner, HJ; Neumann, FJ	1
Boersma, E; Bunt, T; Dambrink, JH; de Boer, MJ; de Winter, R; Ernst, N; Hollak, F; Hoorntje, JC; Jap, W; Marcel Gosselink, AT; Petronio, S; Suryapranata, H; van 't Hof, AW; Zijlstra, F	1
Koehler, B; Meyners, W; Peters, S; Trümmel, M	1
Antman, EM; Braunwald, E; Gibson, CM; Giugliano, RP; Harrington, RA; Morrow, DA; Murphy, SA; Roe, MT; Sabatine, MS	1
Hennebry, TA; Saucedo, JF	1
Baglini, R; Berra Centurini, P; Capuano, C; Danzi, GB; Mauri, L; Sesana, M	1
Ansani, L; Barbieri, D; Bettini, A; Campo, G; Cicchitelli, G; Ferrari, F; Ferrari, R; Guardigli, G; Malagutti, P; Parrinello, G; Percoco, G; Soukhomovskaia, O; Valgimigli, M	1
Ardissino, D; Bilheimer, DW; Blazing, MA; Braunwald, E; Califf, RM; de Lemos, JA; DiBattiste, PM; Fox, KA; Gardner, LH; Hasselblad, V; Lewis, EF; Palmisano, J; Pfeffer, MA; Ramsey, KE; Snapinn, SM; Verheugt, FW; White, HD	1
Dobrzycki, S; Gajewska-Bachórzewska, H; Gugała, K; Kochman, W; Korecki, J; Kralisz, P; Mezyński, G; Musiał, W; Nowak, K; Poniatowski, B; Prokopczuk, P; Zuk, J	1
Brener, SJ; Lincoff, AM; Moliterno, DJ; Steinhubl, SR; Topol, EJ; Wolski, KE	1
Bachorzewska-Gajewska, H; Chlopicki, S; Dobrzycki, S; Gugala, K; Kochman, W; Korecki, J; Kralisz, P; Mezynski, G; Musial, WJ; Niewada, M; Nowak, KS; Poniatowski, B; Prokopczuk, P	1
Domanovits, H; Frossard, M; Fuchs, I; Hsieh, K; Jilma, B; Laggner, AN; Leitner, JM; Losert, H; Schreiber, W; Vlcek, M	1
Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Gibson, CM; Murphy, SA; Singh, KP	1
Akkus, MN; Aytacoğlu, B; Camsari, A; Cicek, D; Cin, VG; Doven, O; Kanik, A; Katircibasi, MT; Pekdemir, H; Sucu, N	1
Dambrink, JH; de Boer, MJ; Ernst, NM; Gosselink, AT; Hoorntje, JC; Miedema, K; Ottervanger, JP; Slingerland, RJ; Suryapranata, H; van 't Hof, AW; Zijlstra, F	1
Antman, EM; Braunwald, E; Cannon, CP; Morrow, DA; Sabatine, MS; Theroux, P	1
Hamm, CW; Heeschen, C; Lantelme, NH; Mitrovic, V; White, HD	1
Gandhi, PJ; Silva, MA	1
Cannon, CP; Dibattiste, PM; Gibson, CM; Karha, J; Murphy, SA	1
Deutsch, HJ; Feldmann, C	1
Bayturan, O; Bilge, AR; Eser, E; Seküri, C; Tezcan, UK; Tikiz, H; Utük, O	1
Graf, C; Nkoulou, R; Perrenoud, JJ; Trombert, V	1
Califf, RM; Crater, SW; Giugliano, RP; Green, CL; Harrington, RA; Johanson, P; Krucoff, MW; Langer, A; Lincoff, AM; Newby, LK; Rebeiz, AG; Roe, MT; Topol, EJ; Wagner, GS	1
Erkoc, R; Eryonucu, B; Tuncer, M	1
Cannizzaro, S; Di Pasquale, P; Paterna, S	1
Dambrink, JH; de Boer, MJ; Gosselink, AT; Hoorntje, JC; Ottervanger, JP; Suryapranata, H; Timmer, JR; van 't Hof, AW; Zijlstra, F	1
DiBattiste, PM; Huynh, T; Pharand, C; Piazza, N; Snapinn, SM; Theroux, P; Wan, Y	1
Ardissino, D; Menozzi, A; Merlini, PA	1
Gehl, HB; Giannitsis, E; Katus, HA; Kulke, C; Lehrke, S; Lima, JA; Merten, C; Richardt, G; Schuster, L; Steen, H; Wiegand, UK	1
Bosco, A; Dunkley, S; Kidson-Gerber, G	1
Ansani, L; Barbieri, D; Bettini, A; Boersma, E; Campo, G; Cicchitelli, G; Ferrari, F; Ferrari, R; Guardigli, G; Malagutti, P; McFadden, EP; Merlini, F; Parrinello, G; Percoco, G; Valgimigli, M	1
Dambrink, JH; de Boer, MJ; De Luca, G; Ernst, N; Gosslink, AT; Hoorntje, JC; Ottervanger, JP; Smit, JJ; Suryapranata, H; van 't Hof, AW	1
Goodman, CN; Kaul, S; Klibanov, AL; Lindner, JR; Sakuma, T; Sari, I	1
Le Pen, C; Lilliu, H	1
Aronson, D; Beyar, R; Boulos, M; Grenadier, E; Gruberg, L; Hammerman, H; Kapeliovich, M; Lavi, S; Markiewicz, W	1
Young, JJ	1
Aroney, CN; Gunasekara, AP; Walters, DL	1
Bocksch, W; Dietz, R; Kühnle, Y; Möckel, M; Nibbe, L; Strohm, S; Vollert, J	1
Antman, EM; Braunwald, E; Califf, RM; de Lemos, JA; DiBattiste, P; Gibson, CM; Harrelson, L; McCabe, C; Ohman, EM; Oliverio, RL; Van de Werf, F	1
Ardissino, D; Bassand, JP; Bertrand, ME; Herrmann, HC; Kristensen, SD; McClure, RR; Moliterno, DJ; Mukherjee, D; Neumann, FJ; Stone, GW; Topol, EJ; Yakubov, SJ	1
Bencsik, P; Csonka, C; Ferdinandy, P; Giricz, Z; Lalu, MM; Schulz, R	1
Badia, T; Bellandi, F; Dabizzi, RP; De Servi, S; Leoncini, M; Maioli, M; Politi, A; Toso, A	1
El Gaylani, N; Osman, F; Pitt, M; Qaisar, S	1
De Luca, L; Sardella, G	1
Dirksen, MT; Kiemeneij, F; Laarman, GJ; Ronner, E; Slagboom, T; van der Wieken, LR; van der Wouw, PA; van Heerebeek, L	1
Chen, JL; Chen, ZJ; Gao, RL; Jing, ZC; Meng, L; Tian, Y; Wu, YJ; Yang, WX; Yang, YJ; You, SJ; Zhao, JL	1
Gao, RL; Jing, ZC; Meng, L; Wang, YW; Wu, YJ; Yang, WX; Yang, YJ; You, SJ; Zhao, JL	1
Glaser, R; Glick, HA; Herrmann, HC; Kimmel, SE	1
Ben-Yehuda, O	1
Akgul, O; Cam, N; Erdem, I; Kasikcioglu, H; Okmen, E; Samur, H; Simsek, D; Tartan, Z; Unal Dayi, S; Uyarel, H; Uzunlar, B	1
Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD	1
Akbulut, T; Akgoz, H; Bilsel, T; Ciloglu, F; Dayi, SU; Ergelen, M; Sayar, N; Terzi, S; Yesilcimen, K	1
Gao, E; Grunwald, Z; Hu, A; Jiao, X; Koch, WJ; Ma, XL; Sharifi-Azad, S; Sun, JZ	1
Bergen, AA; de Jong, PT; Despriet, DD; Hofman, A; Kardys, I; Klaver, CC; Oostra, BA; Uitterlinden, AG; Van Duijn, CM; Witteman, JC	1
Chen, SM; Fang, CY; Fu, M; Guo, GB; Hsieh, YK; Wu, CJ; Yip, HK	1
Dambrink, JH; de Boer, MJ; Ernst, NM; Gosselink, AT; Hoorntje, JC; Kolkman, JJ; Ottervanger, JP; Slingerland, RJ; Smit, JJ; Suryapranata, H; van 't Hof, AW	1
Bonizzoni, E; De Servi, S; Dellavalle, A; Leoncinie, M; Mariani, M; Poletti, F; Politi, A; Vandoni, P	1
Dambrink, JH; de Boer, MJ; Gosselink, M; Hoorntje, JC; Miedema, K; Ottervanger, JP; Rasoul, S; Suryapranata, H; van 't Hof, AW; Zijlstra, F	1
Akbulut, T; Bilsel, T; Emre, A; Ersek, B; Oz, D; Sayar, N; Terzi, S; Ucer, E; Yesilcimen, K	1
Cay, S; Korkmaz, S; Topaloğlu, S	1
Ammendola, C; Cacciapuoti, F; Chiorazzo, G; Cinone, F; Coppola, L; D'Andrea, F; Liberti, D; Marchese, F; Marfella, MA; Marfella, R; Musacchio, E; Nicoletti, GF; Ruggiero, L; Sardu, C; Sasso, FC; Siniscalchi, M; Verza, M	1
Alexander, KP; Chen, AY; Gibler, WB; Hochman, JS; Newby, LK; Ohman, EM; Peterson, ED; Redberg, RF; Roe, MT; Schwartz, JB	1
Alessi, MC; Barbou, F; Bonnet, JL; Cuisset, T; Frère, C; Hovasse, T; Quilici, J; Said, LN	1
Radke, PW; Schunkert, H	1
Berges, A; Timmermans, JP; Van Nassauw, L; Vrints, C	1
Anselmi, M; Campo, G; Catozzi, L; Cicchitelli, G; Ferrari, R; Gemmati, D; Malagutti, P; Percoco, G; Scapoli, G; Tognazzo, S; Valgimigli, M; Vassanelli, C	1
Berger, P; Blankenship, JC; Herrmann, H; Kalyanasundaram, A; McClure, R; Moliterno, D	1
Ligon, RW; Markwell, SJ; Mishkel, GJ; Moore, AL	1
Cui, L; Ge, YG; Li, WM; Liu, Y; Ni, ZH; Wang, HS; Wang, LF; Xu, L; Yang, XC	1
Dambrink, JH; de Boer, MJ; Gosselink, AT; Hoorntje, JC; Ottervanger, JP; Rasoul, S; Suryapranata, H; van 't Hof, AW	1
Chan, L; Christopher, TA; Gao, E; Goldstein, BJ; Jiao, X; Koch, W; Li, S; Lopez, BL; Ma, XL; Tao, L; Yuan, Y	1
Mukherjee, D; Roffi, M	1
Balbarini, A; Ciabatti, N; Cortese, B; De Carlo, M; De Caterina, R; Gistri, R; Levantino, M; Maselli, D; Petronio, AS	1
Cannon, CP; Chen, AY; Gibler, WB; Gibson, CM; Greenbaum, AB; Harrington, RA; Hoekstra, JW; Newby, LK; Ohman, EM; Peterson, ED; Pollack, CV; Roe, MT; Tricoci, P	1
Cameron, VA; Frampton, CM; Mocatta, TJ; Pilbrow, AP; Richards, AM; Senthilmohan, R; Winterbourn, CC	1
Chen, YR; Deng, Y; He, G; Liu, B; Zhou, S; Zhu, X; Zweier, JL	1
Blancas Gómez-Casero, R; Chana García, M; González Manzanares, JL; López Matamala, B; Martín Delgado, C; Martínez Díaz, C; Nevado Losada, E; Serrano Castañeda, J; Yáñez Parareda, E	1
Agostoni, P; Anselmi, M; Arcozzi, C; Bolognese, L; Campo, G; Cohen, DJ; Colangelo, S; de Cesare, N; Ferrari, R; Ferrario, M; Hamon, M; Malagutti, P; Parrinello, G; Pasquetto, G; Percoco, G; Prati, F; Rodriguez, AE; Sheiban, I; Valgimigli, M; Vassanelli, C; Vranckx, P	1
Chang, LT; Chua, S; Hang, CL; Lee, FY; Sheu, JJ; Wu, CJ; Yang, CH; Yeh, KH; Yip, HK; Youssef, AA	1
Arcozzi, C; Barbieri, D; Campo, G; Carletti, R; Ferrari, F; Ferrari, R; Malagutti, P; Parrinello, G; Percoco, G; Valgimigli, M	1
Babu, GJ; Bhupathy, P; Cardounel, AJ; Kalyanasundaram, A; Periasamy, M; Talukder, MA; Zhao, X; Zuo, L; Zweier, JL	1
Arora, R; Deo, D; Deshpande, NV; Hiremath, JS; Hiremath, MS; Joseph, J; Khan, A; Mardikar, HM; Mathew, R; Moliterno, DJ; Mukherjee, D	1
Avci, A; Boztosun, B; Kirma, C; Olcay, A	1
Arcozzi, C; Campo, G; Cohen, DJ; Dulisse, B; Ferrari, R; Isogai, PK; Mittmann, N; Percoco, G; Seung, SJ; Squasi, P; Valgimigli, M	1
Ge, YG; Li, WM; Lian, Y; Ma, LX; Ni, ZH; Wang, HS; Wang, LF; Xia, K; Xu, L; Xue, YL; Yang, XC; Zhang, DP	1
Delgado, C; Fernández-Perez, GC; Rodríguez-Pérez, J; Vázquez, M; Vázquez-Lima, A; Velasco, M	1
Bord, E; Hamada, H; Kishore, R; Lambers, E; Losordo, DW; Qin, G; Rajasingh, J	1
Blazing, MA; Braunwald, E; Califf, RM; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD	1
Bachorzewska-Gajewska, H; Dobrzycki, S; Kochman, W; Korecki, J; Kralisz, P; Musial, WJ; Nowak, K; Poniatowski, B; Prokopczuk, P; Sienkiewicz, J; Sitniewska, E; Zuk, J	1
Banerjee, S; Chen, S; Ho, C; Labinaz, M; Martin, J; Mensinkai, S	1
Koehler, B; Peters, S; Truemmel, M	1
Dambrink, JH; de Boer, MJ; Gosselink, AT; Hoorntje, JC; Kolkman, JJ; Ottervanger, JP; Slingerland, RJ; Smit, JJ; Suryapranata, H; van 't Hof, AW	1
Anilkumar, N; Cave, AC; Grieve, DJ; Looi, YH; Marber, M; Monaghan, MJ; Shah, AM; Siva, A; Walker, SJ	1
Agarwal, A; Cavusoglu, E; Manjappa, N; Marmur, JD; Poludasu, S	1
Shen, J; Zhang, Q; Zhang, RY	1
Boden, WE; Hoekstra, J; Miller, CD	1
Chen, CM; Cheng, ML; Chiu, DT; Gu, PW; Ho, HY	1
Azcona, L; Farré, J; Fernández-Ortiz, A; López-Farré, AJ; Macaya, C; Romero, J; Sacristán, D; Zamorano-León, JJ	1
Fan, WZ; Fu, XH; Geng, W; Gu, XS; Hao, GZ; Hao, QQ; Jia, XW; Jiang, YF; Li, SQ; Wu, WL	1
Bolognese, L; Campo, G; Colangelo, S; de Cesare, N; Ferrari, R; Ferrario, M; Moreno, R; Nazzaro, MS; Parrinello, G; Pasquetto, G; Percoco, G; Piva, T; Prati, F; Rodriguez, AE; Sheiban, I; Valgimigli, M; Vassanelli, C	1
Hu, J; Shen, J; Shen, WF; Yang, ZK; Zhang, JS; Zhang, Q; Zhang, RY; Zhang, X; Zheng, AF	1
Runciman, WB	1
Bolli, R; Cannon, RO; Epstein, SE; Goldstein, RE; Speir, E	1
Laborit, G; Laborit, H	1
Kazarian, AB; Kon'kova, AF; Rass, IT; Shekhaeva, OM; Zaslavskaia, RM	1
Bolli, R; Halliwell, B; Kaur, H; Li, XY; Sun, JZ	1
Gawaz, M; Neumann, FJ; Schömig, A	1
Rossi, G	1
Snapinn, SM	1
Badimon, JJ; Chesebro, JH	1
Adgey, AA	1
Armstrong, PW; Braunwald, E; Califf, RM; Gibler, WB; Hamm, CW; Maseri, A; Simoons, ML; Van de Werf, F	1
Cohen, DJ; Deckelbaum, LI; Gibson, CM; Goel, M; Harris, KE; King, SB; Piana, RN	1
Béguin, S; de Zwaan, C; Hemker, HC; Keularts, IM	1
Braunwald, E; Cannon, CP; Demopoulos, LA; Gormley, GJ; Robertson, DH; Weintraub, WS	1
Liron, M	1
Dykun, Y; Ronner, E; Simoons, ML; van den Brand, MJ; van der Wieken, LR	1
Frojmovic, M; Théroux, P; Xiao, Z	1
Bates, ER	1
Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM	1
Al-Mousa, EN; Arshad, MN; Campsey, M; Gandhi, R; Gibson, CM; Marble, SJ; Mattson, S; Mesley, R; Moynihan, JL; Murphy, S; Ryan, KA; Swanson, J	1
Colombo, A; Dangas, G	1
Chanu, B	1
Phillips, J; Stouffer, GA; Subbarao, VD	1
Klein, WW	1
Kiowski, W; Meyer, BJ; Szucs, TD	1
Dunn, A	1
Tcheng, JE	1
Sax, FL; Snapinn, SM; Théroux, P; Zhao, XQ	1
Boccuzzi, SJ; Burnette, J; Cohen, DJ; Cook, JR; Culler, S; Kosinski, AS; Weintraub, WS	1
Deu, A; Goldmann, B; Hamm, CW; Heeschen, C; Langenbrink, L; White, HD	1
Bell, DM	1
Borzak, S; Cohen, M; Deckelbaum, LI; Diodati, JG; Harris, KE; Huynh, T; Laramée, P; Lo, MW; Sax, FL; Squire, IB; Théroux, P; Thornton, AR; Weber, S; White, HD	1
Wallentin, L	1
Akioka, K; Iwao, H; Kim, S; Omura, T; Takeuchi, K; Teragaki, M; Toda, I; Yamagishi, H; Yoshikawa, J; Yoshiyama, M	1
Lincoff, AM; Roe, MT; Sapp, SK	1
White, HD	1
Amidon, JB; Amidon, TM; Benson, JM; Coffler, D	1
Califf, RM; Lincoff, AM; Topol, EJ	1
Broderick, TM; Kereiakes, DJ; Runyon, JP; Shimshak, TM	1
Collinson, J; Flather, M; Gomma, A; Purcell, H	1
Ferguson, JJ	1
Morais, J	1
Vinten-Johansen, J	1
Chadow, HL; Giarraffa, L; Gunsburg, MY; Hauptman, RE; Rafii, SE; Strom, JA; VanAuker, M	1
Jang, IK; Sabatine, MS	1
Mak, KH; Moliterno, DJ	1
Holmes, DR	1
Bhatt, DL; Topol, EJ	1
Chae, CU; Giugliano, R; Hahn, SS; Jang, IK; Januzzi, JL; Lewandrowski, K; Theroux, P	1
Braunwald, E; Califf, RM; Cannon, CP; Fox, KA; Fuster, V; Gibler, WB; Harrington, RA; King, SB; Kleiman, NS; Theroux, P; Topol, EJ; Van de Werf, F; White, HD; Willerson, JT	1
Alexander, J; Barr, E; Ghannam, AF; Pharand, C; Sax, FL; Snapinn, S; Théroux, P	1
Rasmanis, G; Sylvén, C	1
Agustí, A; Araujo, R	1
Deckelbaum, LI; Dodge, JT; Dotani, I; Gibson, CM; Goel, M; King, SB; Marble, SJ; Murphy, SA	1
Bigonzi, F; Cohen, M; Danchin, N; Fox, KA; Gensini, GF; Gurfinkel, EP; Huber, K; Le-Louer, V; Maritz, F; Timerman, A; Vittori, L; White, H	1
Mitka, M	1
Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G	1
Hamm, C	1
Cohen, M	1
Binder, WD; Brown, DF; Nadel, ES; Reisner, AT	1
Alexander, J; Barr, E; Dupuis, J; Gervais, P; Grandmont, D; Huynh, T; Kouz, S; Laramée, P; Pesant, Y; Sax, FL; Théroux, P	1
Goto, S; Handa, M; Ikeda, Y; Murata, M	1
Goldberg, L; Mekel, J	1
Husted, SE; Rasmussen, S	1
Cannon, CP; Cohen, MC; Hochman, JS; Lucore, CL; O'Rourke, RA; Popma, JJ	1
Auer, J; Berent, R; Eber, B; Maurer, E; Mayr, H; Weber, T	1
Bode, C; Nordt, TK; Peter, K	1
Amarenco, P; Arveiler, D; Cambien, F; Elbaz, A; Evans, A; Gariepy, J; Grandchamp, B; Hetet, G; Kee, F; Morrison, C; Nicaud, V; Simon, A	1
Nurden, P	1
Adam, PC; Evemy, KL; Pemberton, J	1
Vernon, SM	1
Braunwald, E; Cannon, CP; DeLucca, PT; Demopoulos, LA; DiBattiste, PM; Frey, MJ; Gibson, CM; Lakkis, N; Neumann, FJ; Robertson, DH; Vicari, R; Weintraub, WS	1
Bertrand, M; Cohen, DJ; Cohen, EA; Demopoulos, L; DiBattiste, PM; Grines, CL; Herrmann, HC; Moliterno, DJ; Neumann, FJ; Powers, ER; Stone, GW; Topol, EJ	1
Bilheimer, D; Blazing, MA; Braunwald, E; Califf, RM; De Lemos, JA; Dyke, CK	1
Arnold, JM; Feng, Q; Jones, DL; Lu, X; Shen, J	1
Bauersachs, J; Christ, M; Ertl, G; Fraccarollo, D; Galuppo, P	1
Arjmand, R; Arjomand, H; Fischer, HA; Sokil, AB; Wolf, NM	1
Lassila, R	1
Chae, CU; Jang, IK; Januzzi, JL; Sabatine, MS	1
Amerigo, L; Cannizzaro, S; Castello, A; D'Alfonso, G; Pasquale, PD; Sarullo, FM	1
Doggrell, SA	1
Popma, JJ; Suk, J	1
Boden, WE; McKay, RG	1
Cannizzaro, S; Di Pasquale, P; Giambanco, F; Giubilato, A; Paterna, S; Sarullo, FM; Scalzo, S; Vitrano, MG	1
Kini, AS; Mitre, CA; Reich, D; Sharma, SK	1
Fröhlich, E; Möckel, M; Störk, T	1
Barrabés, JA; Blanco, J; Garcia-Dorado, D; Lidón, RM; Mirabet, M; Pizcueta, P; Puigfel, Y; Ruiz-Meana, M; Soler-Soler, J; Soriano, B	1
Chew, DP; Moliterno, DJ	1
Antman, EM; Braunwald, E; McCabe, CH; Morrow, DA; Snapinn, SM; Theroux, P	1
Campbell, P	1
Bakhai, A; Flather, M; Perez de Arenaza, D	1
Denenberg, A; Hake, PW; O'Connor, M; Wong, HR; Yang, Z; Zingarelli, B	1
Brattström, A; Meyners, W; Peters, S; Trümmel, M	1
DiBattiste, PM; Herrmann, HC; Hirshfeld, JW; Kapoor, S; Klugherz, BD; Kolansky, DM; Magness, K; Swierkosz, TA; Tardiff, DC; Valettas, N; Wilensky, RL	1
Moliterno, DJ; Topol, EJ	1
Kereiakes, DJ; Young, JJ	1
Bhatt, DL; Chew, DP	1
Dauterman, KW; Dodge, JT; Dotani, MI; Gibson, CM; Marble, SJ; Michaels, AD; Murphy, SA	1
Kirby, DA; Lown, B; Maher, TJ; Pinto, JM	1
Samofalova, MS	1

Reviews

79 review(s) available for tyrosine and Cardiovascular Stroke

Article	Year
Efficacy and safety of eptifibatide versus tirofiban in acute coronary syndrome patients: A systematic review and meta-analysis. Journal of evidence-based medicine, 2017, Volume: 10, Issue:2 Topics: Acute Coronary Syndrome; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tirofiban; Treatment Outcome; Tyrosine	2017
Acute myocardial infarction associated with thinner abuse: case report and literature review. Clinical toxicology (Philadelphia, Pa.), 2013, Volume: 51, Issue:7 Topics: Adolescent; Adult; Biomarkers; Blood Coagulation Tests; Coronary Angiography; Creatine Kinase, MB Form; Electrocardiography; Fibrinolytic Agents; Humans; Infusions, Intravenous; Inhalation Exposure; Male; Middle Aged; Myocardial Infarction; Platelet Function Tests; Predictive Value of Tests; Solvents; Substance-Related Disorders; Time Factors; Tirofiban; Treatment Outcome; Troponin I; Tyrosine; Up-Regulation; Young Adult	2013
Safety and efficacy of early administration of tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis. Chinese medical journal, 2014, Volume: 127, Issue:6 Topics: Fibrinolytic Agents; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Thrombolytic Therapy; Tirofiban; Tyrosine	2014
Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches. Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:1 Topics: Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Myocardial Infarction; Stroke Volume; Tirofiban; Tyrosine	2015
+Ophitoxaemia and myocardial infarction--the issues during primary angioplasty: a review. BMJ case reports, 2014, Oct-23, Volume: 2014 Topics: Angioplasty; Animals; Antivenins; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Bites; Snake Venoms; Snakes; Tirofiban; Tyrosine	2014
Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis. Medicine, 2015, Volume: 94, Issue:32 Topics: Antithrombins; Cardiac Catheterization; Eptifibatide; Hirudins; Humans; Integrin alpha2; Myocardial Infarction; Peptide Fragments; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Tirofiban; Treatment Outcome; Tyrosine	2015
Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban. Drugs, 2009, Volume: 69, Issue:1 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Time Factors; Tirofiban; Tyrosine	2009
Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. Journal of the American College of Cardiology, 2009, May-05, Volume: 53, Issue:18 Topics: Abciximab; Angioplasty, Balloon; Antibodies, Monoclonal; Anticoagulants; Confidence Intervals; Coronary Angiography; Eptifibatide; Fibrinolytic Agents; Hematologic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2009
[The MULTISTRATEGY study]. Giornale italiano di cardiologia (2006), 2009, Volume: 10, Issue:6 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Stents; Tirofiban; Treatment Outcome; Tyrosine	2009
[The FATA study]. Giornale italiano di cardiologia (2006), 2009, Volume: 10, Issue:6 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2009
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. European heart journal, 2009, Volume: 30, Issue:22 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2009
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2009
Tirofiban for myocardial infarction. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:5 Topics: Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Electrocardiography; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine	2010
Early administration of small-molecule glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from randomized clinical trials. Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:2 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine	2010
Comparison by meta-analysis of eptifibatide and tirofiban to abciximab in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. The American journal of cardiology, 2010, Jul-15, Volume: 106, Issue:2 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Electrocardiography; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2010
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and S JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1 Topics: Abciximab; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Angiography; Coronary Circulation; Drug-Eluting Stents; Evidence-Based Medicine; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; No-Reflow Phenomenon; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Stents; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2011
Safety and efficacy of tirofiban as adjunctive therapy for patients with ST-elevation myocardial infarction: a comparison versus placebo and abciximab. Cardiovascular & hematological agents in medicinal chemistry, 2011, Jul-01, Volume: 9, Issue:3 Topics: Abciximab; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Immunoglobulin Fab Fragments; Meta-Analysis as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine	2011
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis. Current medical research and opinion, 2012, Volume: 28, Issue:3 Topics: Abciximab; Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2012
GP IIb/IIIa inhibitors for STEMI: still the gold standard or an old survivor? Current vascular pharmacology, 2012, Volume: 10, Issue:4 Topics: Abciximab; Animals; Antibodies, Monoclonal; Arrhythmias, Cardiac; Eptifibatide; Evidence-Based Medicine; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2012
Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty. Texas Heart Institute journal, 2012, Volume: 39, Issue:1 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Fatal Outcome; Female; Hemorrhage; Humans; Lung Diseases; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Tirofiban; Tyrosine	2012
TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention. Current opinion in cardiology, 2002, Volume: 17, Issue:4 Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine	2002
Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. Journal of the American College of Cardiology, 2003, Jan-01, Volume: 41, Issue:1 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Randomized Controlled Trials as Topic; Risk; Stents; Survival Analysis; Tirofiban; Tyrosine	2003
[Stratification of cardiac risk in unstable angina: value of troponin measurements]. La Tunisie medicale, 2002, Volume: 80, Issue:10 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Electrocardiography; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Risk Factors; Time Factors; Tirofiban; Troponin; Troponin I; Troponin T; Tyrosine	2002
The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4 Suppl S Topics: Acute Disease; Angina, Unstable; Anticoagulants; Drug Therapy, Combination; Heparin; Humans; Logistic Models; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Recurrence; Risk Assessment; Thrombolytic Therapy; Tirofiban; Troponin; Tyrosine	2003
Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing. Zeitschrift fur Kardiologie, 2003, Volume: 92, Issue:3 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Eptifibatide; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Myocardial Infarction; Peptides; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Time Factors; Tirofiban; Tyrosine	2003
[GP IIb/IIIa receptor prevention medicine]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 4 Topics: Abciximab; Animals; Antibodies, Monoclonal; Aspirin; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tirofiban; Tyrosine	2003
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]. Medizinische Klinik (Munich, Germany : 1983), 2003, Jun-15, Volume: 98, Issue:6 Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine	2003
[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease]. Herz, 2003, Volume: 28, Issue:5 Topics: Abciximab; Administration, Oral; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Controlled Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Emergencies; Eptifibatide; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Time Factors; Tirofiban; Tyrosine	2003
[Role of GP IIb/IIIa blockers in clinical cardiology]. Recenti progressi in medicina, 2003, Volume: 94, Issue:10 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2003
Current management of unstable angina: lessons from the TACTICS-TIMI 18 trial. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2002, Volume: 2, Issue:4 Topics: Angina, Unstable; Angioplasty, Balloon; Aspirin; Dalteparin; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Myocardial Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Thrombolytic Therapy; Tirofiban; Tyrosine	2002
Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Volume: 3, Issue:6 Topics: Abciximab; Angioplasty; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Restenosis; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombosis; Tirofiban; Tyrosine	2003
Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors. Current hematology reports, 2004, Volume: 3, Issue:2 Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Clinical Trials as Topic; Epitopes; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Mice; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombocytopenia; Tirofiban; Tyrosine	2004
Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit. Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:3 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Comorbidity; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Tirofiban; Tyrosine	2004
Use of the early invasive approach in the management of acute coronary syndromes. Current cardiology reports, 2004, Volume: 6, Issue:4 Topics: Angina, Unstable; Cardiac Catheterization; Humans; Myocardial Infarction; Myocardial Revascularization; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	2004
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation, 2004, Aug-24, Volume: 110, Issue:8 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Comorbidity; Coronary Restenosis; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Peptide Fragments; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Stents; Thrombophilia; Ticlopidine; Tirofiban; Tyrosine	2004
Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? Journal of clinical pharmacy and therapeutics, 2004, Volume: 29, Issue:6 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2004
Tirofiban in acute coronary syndromes. Expert review of cardiovascular therapy, 2005, Volume: 3, Issue:2 Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine	2005
[Antithrombotic treatment of acute coronary syndromes without ST-segment elevation]. Deutsche medizinische Wochenschrift (1946), 2006, Nov-24, Volume: 131, Issue:47 Suppl 7 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Tyrosine	2006
Current strategies with high-dose tirofiban. Expert opinion on drug metabolism & toxicology, 2007, Volume: 3, Issue:2 Topics: Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Treatment Outcome; Tyrosine	2007
Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors. International journal of cardiology, 2008, Jan-24, Volume: 123, Issue:3 Topics: Abciximab; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Treatment; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Male; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2008
Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention. The Canadian journal of cardiology, 2007, Volume: 23, Issue:12 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Bleeding Time; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Reoperation; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine	2007
ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy. The American journal of emergency medicine, 2008, Volume: 26, Issue:2 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Electrocardiography; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine; Tirofiban; Tyrosine	2008
Sympathomimetic amines. Anaesthesia and intensive care, 1980, Volume: 8, Issue:3 Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anaphylaxis; Asthma; Cardiopulmonary Bypass; Catechol O-Methyltransferase; Catecholamines; Dopa Decarboxylase; Epinephrine; Eye Diseases; Female; History, 19th Century; History, 20th Century; Humans; Monoamine Oxidase; Myocardial Infarction; Nerve Endings; Neurotransmitter Agents; Obstetric Labor, Premature; Phenylethanolamine N-Methyltransferase; Pregnancy; Receptors, Adrenergic; Receptors, Neurotransmitter; Shock; Shock, Septic; Sympathetic Nervous System; Sympathomimetics; Tyrosine; Tyrosine 3-Monooxygenase; Vasoconstriction	1980
[New experimental data on the physiopathology of myocardial necrosis and its treatment]. Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1983, Volume: 24, Issue:7 Topics: Animals; Aspartic Acid; Glucose; Hypertension; Insulin; Lysosomes; Myocardial Infarction; Potassium; Rabbits; Rats; Solutions; Tyrosine	1983
[Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease]. Deutsche medizinische Wochenschrift (1946), 1997, Oct-02, Volume: 122, Issue:40 Topics: Abciximab; Acetates; Alkynes; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Binding Sites; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Coronary Disease; Double-Blind Method; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Randomized Controlled Trials as Topic; Receptors, Antigen, B-Cell; Receptors, Cell Surface; Time Factors; Tirofiban; Tyrosine	1997
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. European heart journal, 1998, Volume: 19 Suppl D Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	1998
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. European heart journal, 1998, Volume: 19 Suppl D Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	1998
Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention. European heart journal, 1998, Volume: 19, Issue:11 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Disease Progression; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Tyrosine	1998
Platelet glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Current opinion in cardiology, 1998, Volume: 13, Issue:4 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Blood Coagulation; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Treatment Outcome; Tyrosine	1998
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine	1999
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Abciximab; Administration, Oral; Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cardiology; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Embolism; Eptifibatide; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Stents; Structure-Activity Relationship; Tirofiban; Treatment Outcome; Tyrosine	1999
Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization. American heart journal, 1999, Volume: 138, Issue:1 Pt 2 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Thrombosis; Eptifibatide; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Tyrosine	1999
Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. The American journal of the medical sciences, 1999, Volume: 318, Issue:2 Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Angina, Unstable; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	1999
Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes. Pharmacotherapy, 1999, Volume: 19, Issue:9 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tirofiban; Tyrosine; Vascular Surgical Procedures	1999
Efficacy of low-molecular-weight heparin in acute coronary syndromes. American heart journal, 2000, Volume: 139, Issue:2 Pt 2 Topics: Angina, Unstable; Anticoagulants; Biomarkers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Secondary Prevention; Survival Rate; Tirofiban; Treatment Outcome; Troponin T; Tyrosine	2000
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:2 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2000
Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies? The Journal of invasive cardiology, 2000, Volume: 12 Suppl A Topics: Acetates; Angina, Unstable; Anticoagulants; Confidence Intervals; Controlled Clinical Trials as Topic; Enoxaparin; Female; Humans; Male; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Survival Rate; Treatment Outcome; Tyrosine	2000
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. Journal of the American College of Cardiology, 2000, Volume: 35, Issue:5 Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Combined Modality Therapy; Coronary Disease; Drug Monitoring; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Recurrence; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine	2000
Prognostic value of cardiac troponins in patients with acute coronary disease. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2000, Volume: 19, Issue:4 Topics: Abciximab; Antibodies, Monoclonal; Clinical Trials as Topic; Dalteparin; Female; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Male; Multicenter Studies as Topic; Myocardial Infarction; Prognosis; Prospective Studies; Tirofiban; Troponin I; Tyrosine	2000
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. The American journal of medicine, 2000, Aug-15, Volume: 109, Issue:3 Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine	2000
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Current cardiology reports, 1999, Volume: 1, Issue:3 Topics: Acetates; Acute Disease; Eptifibatide; Hemorrhage; Humans; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Tirofiban; Tyrosine	1999
Platelet glycoprotein receptor site blockade in coronary artery disease. Current cardiology reports, 2000, Volume: 2, Issue:1 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Syndrome; Tirofiban; Treatment Outcome; Tyrosine	2000
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA, 2000, Sep-27, Volume: 284, Issue:12 Topics: Abciximab; Acute Disease; Alanine; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Drug Therapy, Combination; Eptifibatide; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Tirofiban; Tyrosine	2000
Redefining medical treatment in the management of unstable angina. The American journal of medicine, 2000, Volume: 108, Issue:1 Topics: Abciximab; Administration, Oral; Angina, Unstable; Antibodies, Monoclonal; C-Reactive Protein; Diagnosis, Differential; Enoxaparin; Eptifibatide; Government Agencies; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; National Institutes of Health (U.S.); Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Risk; Time Factors; Tirofiban; Troponin I; Troponin T; Tyrosine; United States	2000
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease. Clinical cardiology, 2000, Volume: 23 Suppl 6 Topics: Arteriosclerosis; Clopidogrel; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tirofiban; Tyrosine	2000
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation]. Journal des maladies vasculaires, 2000, Volume: 25, Issue:5 Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine	2000
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction. Haemostasis, 2000, Volume: 30 Suppl 3 Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor	2000
[Tirofiban (Aggrastat). A non-peptide glycoprotein IIb/IIIa receptor inhibitor]. Ugeskrift for laeger, 2001, Jan-22, Volume: 163, Issue:4 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Fibrinolytic Agents; Humans; Injections, Intravenous; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine	2001
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction. Archives of internal medicine, 2001, Mar-12, Volume: 161, Issue:5 Topics: Algorithms; Angina, Unstable; Antithrombins; Biomarkers; Diagnosis, Differential; Electrocardiography; Eptifibatide; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Tirofiban; Tyrosine	2001
[Acute coronary syndromes: an update. I. Pathogenesis and drug therapy]. Herz, 2001, Volume: 26, Issue:2 Topics: Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Angina, Unstable; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Terminology as Topic; Ticlopidine; Tirofiban; Tyrosine	2001
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]. Herz, 2001, Volume: 26 Suppl 1 Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tyrosine	2001
[GPIIb-IIIa inhibitors]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2001, Volume: 8, Issue:2 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2001
Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes. Cardiology clinics, 2001, Volume: 19, Issue:2 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Artery Bypass; Dalteparin; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Nadroparin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Transaminases; Tyrosine	2001
ReoPro rules: results from the 'Do Tirofiban and ReoPro Give Similar Efficacy Trial' (TARGET). Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:9 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Stenosis; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Tirofiban; Tyrosine	2001
Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction. The American journal of cardiology, 2001, Oct-18, Volume: 88, Issue:8A Topics: Angina, Unstable; Humans; Myocardial Infarction; Myocardial Revascularization; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Thrombolytic Therapy; Tirofiban; Tyrosine	2001
Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials. Current opinion in cardiology, 2001, Volume: 16, Issue:6 Topics: Acetates; Clinical Trials as Topic; Electrocardiography; Eptifibatide; Heart Conduction System; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2001
GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us. Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:12 Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Atherectomy; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Syndrome; Time Factors; Tirofiban; Treatment Outcome; Troponin T; Tyrosine	2001
Platelet glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: IIb or Not IIb, what is the question? The Journal of invasive cardiology, 2002, Volume: 14, Issue:7 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Intraoperative Care; Male; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tirofiban; Treatment Outcome; Tyrosine	2002
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. Internal medicine journal, 2002, Volume: 32, Issue:7 Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Administration Schedule; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Syndrome; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2002

Trials

166 trial(s) available for tyrosine and Cardiovascular Stroke

Article	Year
Comparison of intracoronary versus intravenous tirofiban in acute ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Coronary artery disease, 2022, 11-01, Volume: 33, Issue:7 Topics: Anterior Wall Myocardial Infarction; Arrhythmias, Cardiac; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Tirofiban; Treatment Outcome; Tyrosine	2022
[Prevention of non-acute stent thrombosis after drug-eluting stent implantation]. Zhonghua wei zhong bing ji jiu yi xue, 2013, Volume: 25, Issue:5 Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Warfarin	2013
Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction. Coronary artery disease, 2013, Volume: 24, Issue:6 Topics: Aged; Aspirin; China; Clopidogrel; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2013
Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial. The Journal of invasive cardiology, 2013, Volume: 25, Issue:8 Topics: Aged; Cardiac Catheterization; Electrocardiography; Female; Follow-Up Studies; Hemorrhage; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prevalence; Prospective Studies; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine	2013
Clinical evaluation of thrombus aspiration combined with tirofiban in patients with acute myocardial infarction with elective percutaneous coronary intervention. The Journal of international medical research, 2013, Volume: 41, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Echocardiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Radiography; Suction; Tirofiban; Treatment Outcome; Tyrosine	2013
Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial. Chinese medical journal, 2013, Volume: 126, Issue:16 Topics: Adult; Aged; Electrocardiography; Female; Fibrinolytic Agents; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Tirofiban; Tyrosine; Urokinase-Type Plasminogen Activator; Ventricular Function, Left	2013
[Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction]. Zhonghua xin xue guan bing za zhi, 2013, Volume: 41, Issue:10 Topics: Adenosine; Aged; Angioplasty, Balloon, Coronary; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2013
Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register. European heart journal. Acute cardiovascular care, 2014, Volume: 3, Issue:1 Topics: Aged; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Preoperative Care; Propensity Score; Registries; Retrospective Studies; Serbia; Survival Rate; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2014
[Effect of intracoronary tirofiban combined with nitroprusside injection through thrombus aspiration catheter during primary percutaneous coronary intervention on acute anterior myocardial infarction patients with heavy thrombosis burden]. Zhonghua xin xue guan bing za zhi, 2014, Volume: 42, Issue:1 Topics: Aged; Cardiac Catheters; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Percutaneous Coronary Intervention; Prognosis; Suction; Tirofiban; Tyrosine	2014
Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction. Minerva cardioangiologica, 2014, Volume: 62, Issue:5 Topics: Adenosine; Aged; Female; Fibrinolytic Agents; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Survival Rate; Tirofiban; Tyrosine; Vasodilator Agents; Verapamil	2014
[The effects of tirofiban on acute non-ST segment elevation myocardial infarction patients not receiving early reperfusion intervention]. Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:3 Topics: Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2014
[Short- or long-outcome of early tirofiban in ST-segment elevated acute myocardial infarction undergoing elective percutaneous coronary intervention]. Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2014
Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology, 2015, Volume: 66, Issue:6 Topics: Aged; Coronary Circulation; Coronary Thrombosis; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Time Factors; Tirofiban; Treatment Outcome; Turkey; Tyrosine	2015
Effects of tirofiban on platelet activation and endothelial function in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cell biochemistry and biophysics, 2015, Volume: 71, Issue:1 Topics: Electrocardiography; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pilot Projects; Platelet Activation; Tirofiban; Treatment Outcome; Tyrosine	2015
Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. Journal of the American Heart Association, 2014, Nov-11, Volume: 3, Issue:6 Topics: Aged; Area Under Curve; Biomarkers; Decision Support Techniques; Female; Hemorrhage; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Patient Discharge; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2014
Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention. European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:23 Topics: Coronary Thrombosis; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Tirofiban; Tyrosine	2014
Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Volume: 85 Suppl 1 Topics: Aged; Biomarkers; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Up-Regulation	2015
Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. European heart journal. Acute cardiovascular care, 2016, Volume: 5, Issue:1 Topics: Aged; Atrial Fibrillation; Biomarkers; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Sensitivity and Specificity; Tirofiban; Troponin T; Tyrosine	2016
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. JAMA, 2015, Apr-07, Volume: 313, Issue:13 Topics: Aged; Antithrombins; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Recombinant Proteins; Tirofiban; Tyrosine	2015
Effect of Intracoronary Plus Low-Dose Intravenous Tirofiban in Elderly Patients with Acute Myocardial Infarction. Heart, lung & circulation, 2015, Volume: 24, Issue:11 Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Stroke Volume; Tirofiban; Troponin T; Tyrosine	2015
The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Volume: 87 Suppl 1 Topics: Aged; Anticoagulants; Antithrombins; Chi-Square Distribution; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Emergency Treatment; Female; Hemorrhage; Heparin; Hirudins; Humans; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Protective Factors; Recombinant Proteins; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2016
Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction. International journal of cardiology, 2016, Apr-01, Volume: 208 Topics: Aged; Coronary Vessels; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Male; Microcirculation; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Tirofiban; Tyrosine	2016
[The effect and safety of tirofiban on acute ST segment elevation myocardial infarction patients receiving no early reperfusion therapy]. Zhonghua nei ke za zhi, 2016, Apr-01, Volume: 55, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Safety; Secondary Prevention; ST Elevation Myocardial Infarction; Tirofiban; Treatment Outcome; Tyrosine	2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American heart journal, 2016, Volume: 177 Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine	2016
In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study. Arquivos brasileiros de cardiologia, 2016, Volume: 107, Issue:5 Topics: Aged; Brazil; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pilot Projects; Placebos; Platelet Aggregation Inhibitors; Postoperative Complications; Predictive Value of Tests; Stents; Time Factors; Tirofiban; Tyrosine	2016
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design. Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:4 Topics: Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Clopidogrel; Double-Blind Method; Drug Resistance; Europe; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Research Design; Ticlopidine; Tirofiban; Treatment Outcome; Troponin I; Troponin T; Tyrosine	2008
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet (London, England), 2008, Aug-16, Volume: 372, Issue:9638 Topics: Angioplasty, Balloon, Coronary; Double-Blind Method; Electrocardiography; Emergency Medical Services; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2008
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). The American journal of cardiology, 2008, Sep-01, Volume: 102, Issue:5 Topics: Atorvastatin; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin; Syndrome; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2008
[Tirofiban or abciximab and sirolimus-eluting or bare metal uncoated stents in primary percutaneous coronary intervention for acute myocardial infarction: results of MULTISTRATEGY trial]. Kardiologiia, 2008, Volume: 48, Issue:7 Topics: Abciximab; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Electrocardiography; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Metals; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Sirolimus; Stents; Tirofiban; Treatment Outcome; Tyrosine	2008
Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes. Thrombosis and haemostasis, 2008, Volume: 100, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Necrosis; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2008
Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial. European heart journal, 2008, Volume: 29, Issue:24 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Dose-Response Relationship, Drug; Drug-Eluting Stents; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Prospective Studies; Tirofiban; Treatment Outcome; Tyrosine	2008
Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: a 1-year follow-up pilot study. Atherosclerosis, 2009, Volume: 204, Issue:2 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Pilot Projects; Recovery of Function; Secondary Prevention; Stents; Time Factors; Treatment Outcome; Tyrosine; Ultrasonography; Ventricular Function, Left	2009
Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction. European journal of clinical investigation, 2009, Volume: 39, Issue:2 Topics: Aged; Aspirin; Clopidogrel; Feasibility Studies; Female; Humans; Iron; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Reproducibility of Results; Stainless Steel; Stents; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2009
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial). The American journal of cardiology, 2009, Mar-15, Volume: 103, Issue:6 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Function, Left	2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Sho Circulation, 2009, Jun-30, Volume: 119, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Drug Resistance; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Tirofiban; Tyrosine	2009
Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study. Clinical cardiology, 2009, Volume: 32, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Circulation; Echocardiography; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardium; Pilot Projects; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Stents; Stroke Volume; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Function, Left	2009
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Emergency Medical Services; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombolytic Therapy; Ticlopidine; Tirofiban; Tyrosine	2009
Safety and efficacy of transradial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience. Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Circulation; Female; Femoral Artery; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Radial Artery; Safety; Stents; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2009
Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention. The American journal of cardiology, 2009, Nov-01, Volume: 104, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Myocardial Infarction; Peptide Fragments; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Retreatment; Thrombocytopenia; Tirofiban; Tyrosine	2009
Evaluation of platelet inhibition by tirofiban in patients stratified according to aspirin and clopidogrel responsiveness: the 3T/2R (Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel). Journal of the American College of Cardiology, 2010, Jan-19, Volume: 55, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cohort Studies; Drug Resistance; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Tyrosine	2010
Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction. Chinese medical journal, 2010, Apr-05, Volume: 123, Issue:7 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Electrocardiography; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Suction; Tirofiban; Treatment Outcome; Tyrosine	2010
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. European heart journal, 2010, Volume: 31, Issue:14 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Tirofiban; Tyrosine	2010
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. Journal of the American College of Cardiology, 2010, Jun-01, Volume: 55, Issue:22 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Emergency Medical Services; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Probability; Prognosis; Prospective Studies; Pulse Therapy, Drug; Reference Values; Risk Assessment; Single-Blind Method; Survival Analysis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2010
Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study. Archives of cardiovascular diseases, 2010, Volume: 103, Issue:5 Topics: Ambulances; Angioplasty, Balloon, Coronary; Biomarkers; Clopidogrel; Coronary Angiography; Coronary Circulation; Creatine Kinase; Drug Administration Schedule; Drug Therapy, Combination; Emergency Medical Services; Female; France; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Troponin I; Tyrosine	2010
Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial. Circulation. Cardiovascular interventions, 2010, Volume: 3, Issue:4 Topics: Angioplasty; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Tirofiban; Treatment Outcome; Tyrosine	2010
Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6, Issue:3 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Diabetes Mellitus; Double-Blind Method; Electrocardiography; Emergency Medical Services; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tirofiban; Treatment Outcome; Tyrosine	2010
Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy. Heart (British Cardiac Society), 2010, Volume: 96, Issue:22 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2010
Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clinical science (London, England : 1979), 2011, Volume: 120, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Animals; Apoptosis; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Ischemic Postconditioning; Leukocyte Count; Male; Malondialdehyde; Middle Aged; Molsidomine; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tyrosine; Ventricular Function, Left	2011
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) tr Journal of the American College of Cardiology, 2010, Oct-26, Volume: 56, Issue:18 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Resistance; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2010
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. Heart (British Cardiac Society), 2011, Volume: 97, Issue:2 Topics: Angioplasty, Balloon, Coronary; Double-Blind Method; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Preoperative Care; Tirofiban; Treatment Outcome; Tyrosine	2011
Upstream tirofiban reduces reperfusion cardiac arrhythmias in patients of acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. International journal of cardiology, 2011, Jan-21, Volume: 146, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Tirofiban; Tyrosine; Young Adult	2011
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy. American heart journal, 2010, Volume: 160, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emergency Medical Services; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Young Adult	2010
Risk of bleeding after prehospital administration of high dose tirofiban for ST elevation myocardial infarction. International journal of cardiology, 2012, May-17, Volume: 157, Issue:1 Topics: Aged; Emergency Medical Services; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Single-Blind Method; Tirofiban; Tyrosine	2012
Long-term reduction of mortality in the 4-year follow up of tirofiban therapy in elective percutaneous coronary interventions (TOPSTAR) trial. The Journal of invasive cardiology, 2011, Volume: 23, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Rate; Ticlopidine; Tirofiban; Treatment Outcome; Troponin; Tyrosine	2011
Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Jan-01, Volume: 79, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Circulation; Echocardiography; Female; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Injections, Intravenous; Male; Microcirculation; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Aggregation Inhibitors; Predictive Value of Tests; Time Factors; Tirofiban; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Turkey; Tyrosine	2012
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab wi Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jun-01, Volume: 77, Issue:7 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Antithrombins; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; United States	2011
The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction. Cardiovascular drugs and therapy, 2011, Volume: 25, Issue:4 Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Double-Blind Method; Electrocardiography; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2011
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7, Issue:4 Topics: Aged; Ambulances; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emergency Medical Services; Female; Fibrinolytic Agents; Health Services Accessibility; Heparin; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Netherlands; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2011
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY). International journal of cardiology, 2013, Apr-30, Volume: 165, Issue:1 Topics: Abciximab; Aged; Antibodies, Monoclonal; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Metals; Middle Aged; Myocardial Infarction; Prospective Studies; Sirolimus; Stents; Tirofiban; Treatment Outcome; Tyrosine	2013
Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study. International journal of cardiology, 2013, May-25, Volume: 165, Issue:3 Topics: Aged; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2013
Comparison of tirofiban combined with dalteparin or unfractionated heparin in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction patients. Chinese medical journal, 2011, Volume: 124, Issue:20 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Dalteparin; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Tirofiban; Treatment Outcome; Tyrosine	2011
The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, May-01, Volume: 79, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency	2012
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban American heart journal, 2012, Volume: 163, Issue:1 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Arrhythmias, Cardiac; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Italy; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Sex Factors; Sirolimus; Tirofiban; Tyrosine	2012
Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction. Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Necrosis; Pilot Projects; Platelet Aggregation Inhibitors; Time Factors; Tirofiban; Tyrosine	2012
Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score. The Journal of invasive cardiology, 2012, Volume: 24, Issue:3 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; Double-Blind Method; Electrocardiography; Emergency Medical Services; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prevalence; Retrospective Studies; Risk Factors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2012
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOppin JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:3 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Italy; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2012
[Effect of early high-loading-dose tirofiban on platelet activity in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Zhonghua xin xue guan bing za zhi, 2012, Volume: 40, Issue:2 Topics: Aged; Blood Platelets; Emergency Treatment; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2012
[High-dose tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Zhonghua yi xue za zhi, 2012, Jul-24, Volume: 92, Issue:28 Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Tirofiban; Tyrosine; Young Adult	2012
Efficacy and safety of standard-dose versus half-dose tirofiban in patients with non-ST elevation acute coronary syndromes undergoing early percutaneous coronary intervention. Cardiovascular therapeutics, 2013, Volume: 31, Issue:4 Topics: Acute Coronary Syndrome; Administration, Intravenous; Aged; Chi-Square Distribution; China; Coronary Angiography; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2013
Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons? Journal of interventional cardiology, 2013, Volume: 26, Issue:2 Topics: Abciximab; Acute Coronary Syndrome; Aged; Antibodies, Monoclonal; Early Termination of Clinical Trials; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Survival Rate; Tirofiban; Treatment Outcome; Tyrosine	2013
Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study). The American journal of cardiology, 2002, Sep-01, Volume: 90, Issue:5 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiac Catheterization; Cardiomyopathies; Combined Modality Therapy; Creatine Kinase; Creatine Kinase, MB Form; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Incidence; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Necrosis; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Stroke Volume; Tirofiban; Treatment Outcome; Troponin I; Tyrosine	2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, an Circulation, 2002, Sep-17, Volume: 106, Issue:12 Topics: Abciximab; Acute Disease; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Citric Acid; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine	2002
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. Lancet (London, England), 2002, Aug-03, Volume: 360, Issue:9330 Topics: Abciximab; Antibodies, Monoclonal; Endpoint Determination; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Tirofiban; Treatment Outcome; Tyrosine	2002
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA, 2002, Oct-16, Volume: 288, Issue:15 Topics: Aged; Angina, Unstable; Cost-Benefit Analysis; Female; Follow-Up Studies; Health Care Costs; Hospital Costs; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Quality-Adjusted Life Years; Tirofiban; Tyrosine; United States	2002
Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA, 2002, Dec-25, Volume: 288, Issue:24 Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Coronary Angiography; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Sex Factors; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Troponin T; Tyrosine	2002
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. Circulation, 2003, Mar-25, Volume: 107, Issue:11 Topics: Angioplasty, Balloon, Coronary; Chemotherapy, Adjuvant; Coronary Angiography; Coronary Thrombosis; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2003
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. European heart journal, 2003, Volume: 24, Issue:15 Topics: Angina, Unstable; Coronary Angiography; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2003
Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction. Heart and vessels, 2003, Volume: 18, Issue:3 Topics: Adult; Aged; Angina, Unstable; Aspirin; Female; Fibrinolytic Agents; Heart Conduction System; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Research Design; Tirofiban; Treatment Outcome; Tyrosine	2003
Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest, 2003, Volume: 124, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIb-IX Complex; Premedication; Recurrence; Stents; Survival Rate; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	2003
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). Journal of the American College of Cardiology, 2003, Oct-01, Volume: 42, Issue:7 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulin Fab Fragments; Louisiana; Male; Middle Aged; Minnesota; Myocardial Infarction; New York City; Ohio; Pennsylvania; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Premedication; Severity of Illness Index; Stents; Survival Analysis; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2003
Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. The American journal of cardiology, 2003, Oct-15, Volume: 92, Issue:8 Topics: Acute Disease; Angioplasty, Balloon, Coronary; Coronary Angiography; Electrocardiography; Emergency Treatment; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Preoperative Care; Tirofiban; Treatment Outcome; Tyrosine	2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. International journal of cardiology, 2003, Volume: 91, Issue:2-3 Topics: Aged; Angina, Unstable; Anticoagulants; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Electrocardiography; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Patient Admission; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Prospective Studies; Risk Factors; Sensitivity and Specificity; Syndrome; Tirofiban; Treatment Outcome; Tyrosine; United Kingdom	2003
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Administration, Oral; Aspirin; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Incidence; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Time Factors; Tirofiban; Tyrosine	2003
Optimizing outcomes in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 2003, Oct-15, Volume: 42, Issue:8 Topics: Drug Therapy, Combination; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2003
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. American heart journal, 2003, Volume: 146, Issue:4 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	2003
Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study). American heart journal, 2003, Volume: 146, Issue:4 Topics: Aged; Angina, Unstable; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sex Factors; Syndrome; Tirofiban; Tyrosine	2003
Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation, 2003, Oct-21, Volume: 108, Issue:16 Suppl 1 Topics: Age Factors; Aged; Anticoagulants; Bundle-Branch Block; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Survival Rate; Tirofiban; Treatment Outcome; Tyrosine	2003
Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction. American heart journal, 2004, Volume: 147, Issue:1 Topics: Analysis of Variance; C-Reactive Protein; Female; Heparin; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tirofiban; Tyrosine	2004
Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction. The American journal of cardiology, 2004, Feb-01, Volume: 93, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Circulation; Electrocardiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2004
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombo Circulation, 2004, Feb-10, Volume: 109, Issue:5 Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Combined Modality Therapy; Creatine Kinase; Creatine Kinase, MB Form; Female; Fibrinolytic Agents; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Sex Factors; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Troponin; Tyrosine	2004
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets, 2004, Volume: 15, Issue:1 Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine	2004
Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial. The American journal of cardiology, 2004, Apr-01, Volume: 93, Issue:7 Topics: Acute Disease; Angina Pectoris; Coronary Artery Bypass; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Myocardial Infarction; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Treatment Outcome; Tyrosine	2004
Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction. The American journal of cardiology, 2004, Apr-01, Volume: 93, Issue:7 Topics: Aged; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Retreatment; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Tyrosine	2004
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. European heart journal, 2004, Volume: 25, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Time Factors; Tirofiban; Transportation of Patients; Treatment Outcome; Tyrosine	2004
Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. The American journal of cardiology, 2004, Jul-01, Volume: 94, Issue:1 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Echocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Left	2004
High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patients. Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:3 Topics: Abciximab; Antibodies, Monoclonal; Clinical Protocols; Coronary Restenosis; Drug Implants; Drug Therapy, Combination; Electrocardiography; Female; Forecasting; Humans; Immunoglobulin Fab Fragments; Injections; Italy; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sirolimus; Stents; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2004
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA, 2004, Jul-07, Volume: 292, Issue:1 Topics: Aged; Angina Pectoris; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2004
Platelet inhibition by increased tirofiban dosing during primary coronary angioplasty for ST elevation myocardial infarction. Kardiologia polska, 2004, Volume: 60, Issue:5 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2004
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy). The American journal of cardiology, 2004, Aug-15, Volume: 94, Issue:4 Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Coronary Angiography; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Premedication; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	2004
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 2004, Sep-15, Volume: 44, Issue:6 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Survival Analysis; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2004
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). The American journal of cardiology, 2004, Sep-15, Volume: 94, Issue:6 Topics: Acute Disease; Angina Pectoris; Female; Fibrinolytic Agents; Heparin; Humans; Male; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2004
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation, 2004, Nov-16, Volume: 110, Issue:20 Topics: Acute Disease; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Follow-Up Studies; Heparin; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Risk; Risk Assessment; Syndrome; Tirofiban; Troponin T; Tyrosine	2004
The effect of tirofiban on ST segment resolution in patients with non-ST elevated myocardial infarction. Japanese heart journal, 2004, Volume: 45, Issue:6 Topics: Electrocardiography; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Prognosis; Tirofiban; Treatment Outcome; Tyrosine	2004
Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction. American heart journal, 2005, Volume: 149, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Electrocardiography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Prospective Studies; Stents; Tirofiban; Tyrosine	2005
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA, 2005, May-04, Volume: 293, Issue:17 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Drug Delivery Systems; Female; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Single-Blind Method; Sirolimus; Stents; Tirofiban; Tyrosine	2005
The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients. The Journal of invasive cardiology, 2005, Volume: 17, Issue:6 Topics: Abciximab; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Treatment Outcome; Tyrosine	2005
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. American heart journal, 2005, Volume: 150, Issue:1 Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Tenecteplase; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. European heart journal, 2005, Volume: 26, Issue:23 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2005
Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstrea American heart journal, 2005, Volume: 150, Issue:3 Topics: Abciximab; Acute Disease; Aged; Angina, Unstable; Antibodies, Monoclonal; Clopidogrel; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Infarction; Necrosis; Prospective Studies; Syndrome; Ticlopidine; Time Factors; Tirofiban; Troponin I; Tyrosine	2005
Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial. The Journal of invasive cardiology, 2005, Volume: 17, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Feasibility Studies; Female; Femoral Artery; Follow-Up Studies; Humans; Length of Stay; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Prospective Studies; Stents; Tirofiban; Tyrosine	2005
Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty. Heart and vessels, 2006, Volume: 21, Issue:2 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2006
Angiographic and clinical outcome in ST-segment elevation myocardial infarction patients receiving an adjunctive double bolus regimen of tirofiban for primary percutaneous coronary intervention. Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:5 Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Recurrence; Tirofiban; Treatment Outcome; Tyrosine	2006
Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome. American heart journal, 2006, Volume: 151, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2006
A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial. European heart journal, 2006, Volume: 27, Issue:12 Topics: Aged; Aspirin; Clopidogrel; Disease-Free Survival; Drug Combinations; Enzymes; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2006
Impact of early tirofiban administration on myocardial salvage in patients with acute myocardial infarction undergoing infarct-related artery stenting. Cardiology, 2006, Volume: 106, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Radiopharmaceuticals; Salvage Therapy; Stents; Technetium Tc 99m Sestamibi; Tirofiban; Treatment Outcome; Tyrosine	2006
Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:9 Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cytokines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Mediterranean; Follow-Up Studies; Heart; Humans; Middle Aged; Myocardial Infarction; Oxidative Stress; Prognosis; Treatment Outcome; Tyrosine; Wine	2006
Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Apr-01, Volume: 69, Issue:5 Topics: Abciximab; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Reoperation; Research Design; Risk Factors; Saphenous Vein; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine; Venous Thrombosis	2007
[Effect of pre-angiography use of tirofiban in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention]. Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:11 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2006
Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison. Journal of thrombosis and thrombolysis, 2007, Volume: 24, Issue:3 Topics: Aged; Coronary Angiography; Creatine Kinase; Drug Administration Routes; Electrocardiography; Female; Fibrinolytic Agents; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Tirofiban; Tyrosine	2007
[Absence of benefit with triple antiaggregation in acute non persistent ST segment elevation myocardial infarction in patients not subjected to early interventionism]. Medicina intensiva, 2007, Volume: 31, Issue:4 Topics: Aged; Aspirin; Clopidogrel; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Tyrosine	2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEG American heart journal, 2007, Volume: 154, Issue:1 Topics: Abciximab; Antibodies, Monoclonal; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Metals; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Research Design; Sirolimus; Stents; Tirofiban; Tyrosine	2007
Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:7 Topics: Aged; Angioplasty, Balloon; Clopidogrel; Cohort Studies; Electrocardiography; Female; Humans; Interleukin-10; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2007
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study. Journal of the American College of Cardiology, 2007, Jul-10, Volume: 50, Issue:2 Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Restenosis; Disease-Free Survival; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Prosthesis Design; Risk; Sirolimus; Stents; Tirofiban; Tyrosine	2007
Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study. American heart journal, 2007, Volume: 154, Issue:2 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Clopidogrel; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Registries; Ticlopidine; Tirofiban; Tyrosine	2007
A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. International journal of cardiology, 2008, Aug-01, Volume: 128, Issue:1 Topics: Abciximab; Aged; Antibodies, Monoclonal; Cost Control; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Hospital Costs; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Statistics, Nonparametric; Stents; Tirofiban; Treatment Outcome; Tyrosine	2008
[Effects of intracoronary or intravenous tirofiban administration in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Zhonghua xin xue guan bing za zhi, 2007, Volume: 35, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Electrocardiography; Emergency Treatment; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Tirofiban; Treatment Outcome; Tyrosine	2007
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). The American journal of cardiology, 2007, Oct-01, Volume: 100, Issue:7 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Tirofiban; Treatment Outcome; Tyrosine	2007
Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. European heart journal, 2007, Volume: 28, Issue:20 Topics: Aged; Angioplasty, Balloon, Coronary; Female; Fibrinolytic Agents; Hospitals, Community; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Poland; Risk Factors; Survival Rate; Thrombolytic Therapy; Tirofiban; Tyrosine	2007
Facilitated PCI by combination fibrinolysis or upstream tirofiban in acute ST-segment elevation myocardial infarction: results of the Alteplase and Tirofiban in Acute Myocardial Infarction (ATAMI) trial. International journal of cardiology, 2008, Nov-12, Volume: 130, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Drug Therapy, Combination; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2008
Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction. Thrombosis research, 2008, Volume: 122, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Double-Blind Method; Female; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Prognosis; Prospective Studies; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2008
[Clinical outcomes and safety of primary percutaneous coronary intervention combined with tirofiban therapy in patients with acute ST-segment elevation myocardial infarction]. Zhonghua xin xue guan bing za zhi, 2007, Volume: 35, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chemotherapy, Adjuvant; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Safety; Tirofiban; Treatment Outcome; Tyrosine	2007
Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation. Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:3 Topics: Aged; alpha 1-Antitrypsin; Clopidogrel; Drug Administration Schedule; Female; Humans; Inflammation; Infusions, Intravenous; Male; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Time Factors; Tirofiban; Tyrosine	2008
Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Chinese medical journal, 2008, Mar-20, Volume: 121, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Tyrosine; Vasodilation	2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA, 2008, Apr-16, Volume: 299, Issue:15 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Tyrosine	2008
Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coronary artery disease, 2008, Volume: 19, Issue:4 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Prospective Studies; Tirofiban; Tyrosine	2008
Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban Circulation, 1997, Sep-02, Volume: 96, Issue:5 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Bypass; Coronary Thrombosis; Double-Blind Method; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIb-IX Complex; Postoperative Complications; Retreatment; Time Factors; Tirofiban; Tyrosine	1997
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. The New England journal of medicine, 1998, 05-21, Volume: 338, Issue:21 Topics: Aged; Angina, Unstable; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Tirofiban; Tyrosine	1998
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. The New England journal of medicine, 1998, 05-21, Volume: 338, Issue:21 Topics: Aged; Angina, Unstable; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Tirofiban; Tyrosine	1998
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Gl Circulation, 1998, Jun-23, Volume: 97, Issue:24 Topics: Acetates; Aged; Angina, Unstable; Anticoagulants; Aspirin; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Analysis; Tyrosine	1998
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Journal of the American College of Cardiology, 1998, Volume: 32, Issue:1 Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Recurrence; Reoperation; Tirofiban; Treatment Outcome; Tyrosine	1998
Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients. Thrombosis and haemostasis, 1998, Volume: 80, Issue:3 Topics: Angina, Unstable; Heparin; Humans; Injections, Intravenous; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Tirofiban; Tyrosine	1998
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Th The American journal of cardiology, 1998, Sep-15, Volume: 82, Issue:6 Topics: Adolescent; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Research Design; Tirofiban; Treatment Outcome; Tyrosine	1998
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. Journal of the American College of Cardiology, 1998, Volume: 32, Issue:7 Topics: Acetates; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Treatment Outcome; Tyrosine	1998
Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor. Thrombosis and haemostasis, 1999, Volume: 81, Issue:2 Topics: Aged; Amino Acid Sequence; Angina, Unstable; Blood Platelets; Cell Aggregation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fibrinogen; Flow Cytometry; Heparin; Humans; Male; Middle Aged; Molecular Sequence Data; Myocardial Infarction; Neutrophils; P-Selectin; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, Thrombin; Tirofiban; Tyrosine	1999
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Abciximab; Administration, Oral; Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cardiology; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Embolism; Eptifibatide; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Stents; Structure-Activity Relationship; Tirofiban; Treatment Outcome; Tyrosine	1999
[Inhibitors of GPIIb/IIIa platelet receptors]. Archives des maladies du coeur et des vaisseaux, 1999, Volume: 92, Issue:7 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Cerebrovascular Disorders; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine	1999
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome managemen Circulation, 1999, Oct-12, Volume: 100, Issue:15 Topics: Aged; Angina, Unstable; Anticoagulants; Arteriosclerosis; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	1999
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Combined Modality Therapy; Coronary Disease; Cost-Benefit Analysis; Double-Blind Method; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Retreatment; Risk Factors; Tirofiban; Tyrosine; United States	1999
Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet (London, England), 1999, Nov-20, Volume: 354, Issue:9192 Topics: Aged; Biomarkers; Coronary Disease; Creatine Kinase; Female; Fibrinolytic Agents; Heparin; Humans; Infusions, Intravenous; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Tirofiban; Troponin I; Troponin T; Tyrosine	1999
Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. International journal of cardiology, 1999, Dec-01, Volume: 71, Issue:3 Topics: Angina, Unstable; Coronary Angiography; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Injections, Intravenous; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Syndrome; Tirofiban; Treatment Outcome; Tyrosine	1999
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee. American heart journal, 2000, Volume: 139, Issue:4 Topics: Acetates; Adult; Aged; Cohort Studies; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Rate; Tyrosine	2000
Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Uns Circulation, 2000, Nov-14, Volume: 102, Issue:20 Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Diabetes Complications; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heparin; Humans; Infusions, Intravenous; Likelihood Functions; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2000
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Collateral Circulation; Confidence Intervals; Coronary Circulation; Coronary Disease; Coronary Vessels; Double-Blind Method; Fibrinolytic Agents; Humans; Multivariate Analysis; Myocardial Infarction; Placebos; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Stents; Tirofiban; Treatment Outcome; Tyrosine	2000
The TETAMI trial: the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: methods and design. Journal of thrombosis and thrombolysis, 2000, Volume: 10, Issue:3 Topics: Adult; Aged; Clinical Protocols; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Placebos; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Survival Rate; Tirofiban; Tyrosine	2000
Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes. The Journal of invasive cardiology, 2000, Volume: 12 Suppl E Topics: Angina, Unstable; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Tirofiban; Tyrosine	2000
Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators. The American journal of cardiology, 2001, Feb-15, Volume: 87, Issue:4 Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Canada; Cardiac Catheterization; Double-Blind Method; Female; Heparin; Hospitals; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine	2001
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. The New England journal of medicine, 2001, Jun-21, Volume: 344, Issue:25 Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine	2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. The New England journal of medicine, 2001, Jun-21, Volume: 344, Issue:25 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Tirofiban; Tyrosine	2001
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy. American heart journal, 2001, Volume: 142, Issue:2 Topics: Anticoagulants; Drug Therapy, Combination; Enoxaparin; Humans; Hypolipidemic Agents; Myocardial Infarction; Patient Selection; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Simvastatin; Tirofiban; Tyrosine	2001
Elevation in serum troponin I predicts the benefit of tirofiban. Journal of thrombosis and thrombolysis, 2001, Volume: 11, Issue:3 Topics: Acute Disease; Aged; Biomarkers; Coronary Disease; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Survival Rate; Tirofiban; Troponin I; Tyrosine	2001
Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings. Italian heart journal : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:8 Topics: Creatine Kinase; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2001
Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. Italian heart journal : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:10 Topics: Abciximab; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Coronary Angiography; Drug Therapy, Combination; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Risk Factors; Single-Blind Method; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2001
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. European heart journal, 2002, Volume: 23, Issue:3 Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Biomarkers; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Endpoint Determination; Follow-Up Studies; Heparin; Humans; Isoenzymes; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Assessment; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine	2002
Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes. Circulation, 2002, Jan-22, Volume: 105, Issue:3 Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Endpoint Determination; Female; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Titrimetry; Treatment Outcome; Tyrosine	2002
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention. The American journal of cardiology, 2002, Jun-01, Volume: 89, Issue:11 Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Tyrosine	2002
Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. American heart journal, 2002, Volume: 144, Issue:1 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Atherectomy; Blood Flow Velocity; Collateral Circulation; Coronary Circulation; Double-Blind Method; Fibrinolytic Agents; Humans; Myocardial Infarction; Prognosis; Tirofiban; Tyrosine	2002

Other Studies

214 other study(ies) available for tyrosine and Cardiovascular Stroke

Article	Year
Antithrombotic Activity of the Antiplatelet Agent Angipur on the Model of Arterial Thrombosis in Rats with Isoproterenol-Induced Myocardial Infarction. Bulletin of experimental biology and medicine, 2022, Volume: 172, Issue:3 Topics: Animals; Fibrinolytic Agents; Isoproterenol; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis; Tyrosine	2022
Micro-Raman spectroscopy study of blood samples from myocardial infarction patients. Lasers in medical science, 2022, Volume: 37, Issue:9 Topics: Humans; Inflammation; Myocardial Infarction; Phenylalanine; Spectrum Analysis, Raman; Tyrosine	2022
Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction. Matrix biology : journal of the International Society for Matrix Biology, 2022, Volume: 112 Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Fibroblasts; Fibrosis; Heart Failure; Mice; Myocardial Infarction; Myocardium; Myofibroblasts; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tyrosine; Ventricular Remodeling	2022
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality. European heart journal, 2023, 08-22, Volume: 44, Issue:32 Topics: Amino Acids, Aromatic; Animals; Disease Progression; Gastrointestinal Microbiome; Glucuronides; Glutamine; Humans; Indoles; Mice; Myocardial Infarction; Tryptophan; Tyrosine	2023
Crystal structure and receptor-interacting residues of MYDGF - a protein mediating ischemic tissue repair. Nature communications, 2019, 11-26, Volume: 10, Issue:1 Topics: Antibodies, Neutralizing; Cells, Cultured; Coronary Vessels; Crystallography, X-Ray; Epitopes; Humans; Interleukins; Models, Molecular; Mutation; Myocardial Infarction; Protein Conformation; Protein Folding; Sequence Homology, Amino Acid; Tyrosine	2019
Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage. Cardiology journal, 2021, Volume: 28, Issue:2 Topics: Adult; Blood Platelets; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine; Walking	2021
MARK4 controls ischaemic heart failure through microtubule detyrosination. Nature, 2021, Volume: 594, Issue:7864 Topics: Angiogenic Proteins; Animals; Carboxypeptidases; Cells, Cultured; Heart Failure; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Microtubules; Myocardial Infarction; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Stroke Volume; Tyrosine; Ventricular Function, Left	2021
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Annals of the rheumatic diseases, 2021, Volume: 80, Issue:11 Topics: Adult; Alanine; Angina Pectoris; Apolipoproteins B; Arthritis, Psoriatic; Cardiovascular Diseases; Cholesterol; Fatty Acids, Unsaturated; Female; Heart Failure; Humans; Ischemic Attack, Transient; Lipoproteins, HDL; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Psoriasis; Risk Assessment; Stroke; Tyrosine	2021
Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2. Cardiovascular research, 2017, Jul-01, Volume: 113, Issue:8 Topics: Animals; Enzyme Activation; Focal Adhesion Kinase 2; Hydrogen Peroxide; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Rats; Tyrosine	2017
Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis. Medical science monitor : international medical journal of experimental and clinical research, 2017, Apr-30, Volume: 23 Topics: Aged; Aged, 80 and over; Arteries; Embolism; Female; Hemorrhage; Humans; Knee Joint; Leg; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombectomy; Thromboembolism; Tirofiban; Treatment Outcome; Tyrosine	2017
Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis. Pharmacotherapy, 2017, Volume: 37, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Intraoperative Care; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Renal Dialysis; Retrospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine	2017
Alginate oligosaccharide alleviates myocardial reperfusion injury by inhibiting nitrative and oxidative stress and endoplasmic reticulum stress-mediated apoptosis. Drug design, development and therapy, 2017, Volume: 11 Topics: Alginates; Animals; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Endoplasmic Reticulum Stress; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Nitrosative Stress; Oligosaccharides; Oxidative Stress; Superoxides; Tyrosine	2017
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. Thrombosis research, 2018, Volume: 164 Topics: Aged; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2018
Role of Exercise-Induced Cardiac Remodeling in Ovariectomized Female Rats. Oxidative medicine and cellular longevity, 2018, Volume: 2018 Topics: Animal Nutritional Physiological Phenomena; Animals; Collagen Type I; Estrogens; Female; Glutathione; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Ovariectomy; Physical Conditioning, Animal; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-2; Tyrosine; Ventricular Remodeling	2018
Protein kinases are involved in the cardioprotective effects activated by platelet glycoprotein IIb/IIIa inhibitor tirofiban at reperfusion in rats in vivo. European journal of pharmacology, 2018, Aug-05, Volume: 832 Topics: Animals; Cardiotonic Agents; Enzyme Activation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C-epsilon; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Tirofiban; Tyrosine	2018
Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Medicine, 2018, Volume: 97, Issue:21 Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon, Coronary; Catheters; Drug Administration Routes; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Stroke; Tirofiban; Treatment Outcome; Tyrosine	2018
Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure. Nature medicine, 2018, Volume: 24, Issue:8 Topics: Cell Proliferation; Desmin; Elasticity; Heart Failure; Humans; Intermediate Filaments; Microtubules; Muscle Cells; Myocardial Infarction; Myocytes, Cardiac; Proteomics; Tyrosine; Up-Regulation; Viscosity	2018
Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium. PloS one, 2018, Volume: 13, Issue:8 Topics: Animals; Dose-Response Relationship, Drug; Heart; Magnesium; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Norepinephrine; Proton Pump Inhibitors; Rats; Rats, Wistar; Signal Transduction; Superoxides; Sympathetic Nervous System; Tyrosine; Ventricular Remodeling	2018
The impact of sex and myocardial ischemic preconditioning on immunohistochemical markers of acute myocardial infarction. International journal of legal medicine, 2019, Volume: 133, Issue:2 Topics: Animals; Biomarkers; Connexin 43; Female; Forensic Medicine; Immunohistochemistry; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats, Wistar; Sex Factors; Troponin I; Tyrosine	2019
The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction. Blood, 2019, 01-24, Volume: 133, Issue:4 Topics: Alleles; Case-Control Studies; Female; Gain of Function Mutation; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Risk Factors; Tyrosine; von Willebrand Factor	2019
Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling. Cardiovascular therapeutics, 2018, Volume: 36, Issue:6 Topics: Animals; Creatine Kinase, MB Form; Disease Models, Animal; Isolated Heart Preparation; Male; Morphine Derivatives; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Troponin T; Tyrosine	2018
PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4 Topics: Abciximab; Aged; Amino Acid Substitution; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; Drug Administration Schedule; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Leucine; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Proline; Tirofiban; Treatment Outcome; Tyrosine	2013
Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban. Chinese medical journal, 2013, Volume: 126, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Tirofiban; Tyrosine	2013
Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. Journal of the American Heart Association, 2013, Jan-02, Volume: 2, Issue:1 Topics: Animals; Biopterins; Cell Death; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitrates; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Superoxides; Time Factors; Tyrosine	2013
The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades. Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:9 Topics: Animals; Arachidonate 5-Lipoxygenase; Cardiotonic Agents; Caspase 3; Cyclooxygenase 2; DNA Fragmentation; Gene Expression Regulation; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Intercellular Adhesion Molecule-1; Lipoxygenase Inhibitors; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Peroxidase; Rats; Rats, Wistar; Triterpenes; Tumor Necrosis Factor-alpha; Tyrosine	2013
Breathing nitric oxide plus hydrogen gas reduces ischemia-reperfusion injury and nitrotyrosine production in murine heart. American journal of physiology. Heart and circulatory physiology, 2013, Aug-15, Volume: 305, Issue:4 Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Inhalation; Aldehydes; Animals; Antioxidants; Cardiotonic Agents; Deoxyguanosine; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Gases; Hydrogen; Immunohistochemistry; Inhalation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; Nitric Oxide; Oxidative Stress; Receptors, Cell Surface; Time Factors; Tyrosine; Ventricular Function, Left	2013
Short-term effect of upstream administration in comparison to deferred injection of tirofiban on patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Journal of interventional cardiology, 2013, Volume: 26, Issue:4 Topics: Aged; Coronary Angiography; Electrocardiography; Female; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stroke Volume; Tirofiban; Tyrosine; Ventricular Function, Left	2013
Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo. PloS one, 2013, Volume: 8, Issue:7 Topics: Animals; Cardiotonic Agents; Cytoprotection; Heart; Ischemic Postconditioning; Male; Metalloporphyrins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peroxynitrous Acid; Rats; Rats, Wistar; Tyrosine	2013
Transradial access should be preferred in all patients with acute coronary syndrome? The game is not yet over. Chinese medical journal, 2013, Volume: 126, Issue:14 Topics: Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Tyrosine	2013
Glycoprotein IIb/III inhibition during acute percutaneous coronary intervention: tool or talisman? Journal of interventional cardiology, 2013, Volume: 26, Issue:4 Topics: Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2013
High dose remifentanil increases myocardial oxidative stress and compromises remifentanil infarct-sparing effects in rats. European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Analgesics, Opioid; Animals; Deoxyguanosine; Dose-Response Relationship, Drug; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Oxidative Stress; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Superoxide Dismutase; Superoxides; Tyrosine	2013
Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovascular diabetology, 2013, Sep-17, Volume: 12 Topics: Animals; Biomarkers; Caspase 3; Creatine Kinase, BB Form; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dinoprost; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Severity of Illness Index; STAT3 Transcription Factor; Stroke Volume; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine; Ventricular Function, Left; Ventricular Pressure	2013
Effects of upstream administration of tirofiban before percutaneous coronary intervention on spontaneous reperfusion and clinical outcomes in acute ST-segment elevation myocardial infarction. Angiology, 2015, Volume: 66, Issue:1 Topics: Aged; Chi-Square Distribution; Combined Modality Therapy; Coronary Circulation; Disease-Free Survival; Drug Administration Schedule; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2015
Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction. Journal of the American Heart Association, 2014, Feb-21, Volume: 3, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cell Movement; Disease Models, Animal; Lac Operon; Male; Mice; Mice, Transgenic; Myocardial Infarction; Myocytes, Cardiac; Reactive Nitrogen Species; Reactive Oxygen Species; Stem Cell Transplantation; Stem Cells; Time Factors; Tyrosine; Ventricular Remodeling	2014
The safety and efficacy of 12 versus 24 hours of tirofiban infusion in patients undergoing primary percutaneous coronary intervention. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2015, Volume: 21, Issue:8 Topics: Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Care; Retrospective Studies; Time Factors; Tirofiban; Tyrosine	2015
Dityrosine, a protein product of oxidative stress, as a possible marker of acute myocardial infarctions. International journal of legal medicine, 2014, Volume: 128, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Child; Child, Preschool; Complement Membrane Attack Complex; Female; Fibronectins; Humans; Immunohistochemistry; Male; Middle Aged; Myocardial Infarction; Myocardium; Oxidative Stress; Time Factors; Tyrosine; Young Adult	2014
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 10, Issue:10 Topics: Abciximab; Aged; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Survival Analysis; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine	2015
Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy. European heart journal, 2015, Feb-07, Volume: 36, Issue:6 Topics: Absorbable Implants; Adenosine; Adult; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Graft Occlusion, Vascular; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stents; Ticagrelor; Ticlopidine; Tirofiban; Tissue Scaffolds; Tyrosine	2015
Influence of N- acetylcysteine on oxidative stress in slow-twitch soleus muscle of heart failure rats. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:1 Topics: Acetylcysteine; Animals; Ethidium; Free Radical Scavengers; Glutathione Peroxidase; Heart Failure; Heart Ventricles; Male; Malondialdehyde; Muscle, Skeletal; Myocardial Infarction; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Tyrosine	2015
Can BRIGHT restore the glow of bivalirudin? JAMA, 2015, Apr-07, Volume: 313, Issue:13 Topics: Antithrombins; Female; Fibrinolytic Agents; Heparin; Hirudins; Humans; Male; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Recombinant Proteins; Tirofiban; Tyrosine	2015
The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI. Anatolian journal of cardiology, 2015, Volume: 15, Issue:11 Topics: Aged; Coronary Angiography; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Retrospective Studies; Tirofiban; Treatment Outcome; Tyrosine	2015
Varying Responses to Antithrombotic Treatment by Race/Ethnicity. JAMA, 2015, Aug-11, Volume: 314, Issue:6 Topics: Antithrombins; Female; Fibrinolytic Agents; Heparin; Humans; Male; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Tyrosine	2015
Varying Responses to Antithrombotic Treatment by Race/Ethnicity--Reply. JAMA, 2015, Aug-11, Volume: 314, Issue:6 Topics: Antithrombins; Female; Fibrinolytic Agents; Heparin; Humans; Male; Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Tyrosine	2015
Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovascular diabetology, 2015, Nov-18, Volume: 14 Topics: Animals; Apoptosis Regulatory Proteins; Arrhythmias, Cardiac; Autophagy; Autophagy-Related Protein 7; Autophagy-Related Protein-1 Homolog; Beclin-1; Heat-Shock Proteins; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Sequestosome-1 Protein; Severity of Illness Index; Signal Transduction; Stress, Physiological; TOR Serine-Threonine Kinases; Tyrosine; Ubiquitin-Activating Enzymes	2015
Diffused alveolar hemorrhage: A rare and severe complication of tirofiban-induced thrombocytopenia. International journal of cardiology, 2016, Mar-01, Volume: 206 Topics: Aged; Coronary Occlusion; Hemorrhage; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Thrombocytopenia; Tirofiban; Tyrosine	2016
In Reply: Safety and Efficacy Issues of Tirofiban Use in Endovascular Procedures: What Are the Actual Indications? Neurosurgery, 2016, Volume: 78, Issue:6 Topics: Endovascular Procedures; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2016
Letter: Safety and Efficacy Issues of Tirofiban Use in Endovascular Procedures: What Are the Actual Indications? Neurosurgery, 2016, Volume: 78, Issue:6 Topics: Endovascular Procedures; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2016
Dityrosine as a marker of acute myocardial infarction? Experiments with the isolated Langendorff heart. International journal of legal medicine, 2016, Volume: 130, Issue:4 Topics: Animals; Biomarkers; Disease Models, Animal; Immunohistochemistry; Isolated Heart Preparation; Myocardial Infarction; Myocardium; Rats, Wistar; Tyrosine	2016
Thrombus Aspirated from Patients with ST-Elevation Myocardial Infarction: Association between 3-Nitrotyrosine and Inflammatory Markers - Insights from ARTERIA Study. International journal of medical sciences, 2016, Volume: 13, Issue:7 Topics: Aged; Biomarkers; C-Reactive Protein; CD40 Ligand; Coronary Thrombosis; Enzyme-Linked Immunosorbent Assay; Female; Hemoglobins; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Percutaneous Coronary Intervention; Tyrosine; Vascular Cell Adhesion Molecule-1	2016
Circulation. Heart failure, 2017, Volume: 10, Issue:2 Topics: Adult; Animals; Calcium Channels, L-Type; Calcium Signaling; Calcium-Binding Proteins; Cardiomyopathies; Case-Control Studies; Disease Models, Animal; Female; Genetic Predisposition to Disease; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Phenotype; Potassium Channels, Inwardly Rectifying; Reactive Nitrogen Species; Reactive Oxygen Species; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tyrosine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure	2017
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis? Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:11 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right	2008
Mechanical reperfusion: treat well, treat on time too. Lancet (London, England), 2008, Aug-16, Volume: 372, Issue:9638 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Emergency Medical Services; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2008
Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:6 Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Biological Availability; Drug Therapy, Combination; Echocardiography; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Nitric Oxide; Quinolines; Rabbits; Reactive Oxygen Species; Tetrazoles; Tyrosine; Valine; Valsartan	2008
Intracoronary thrombus aspiration through a guiding catheter in a case with stent thrombosis. The Journal of invasive cardiology, 2008, Volume: 20, Issue:10 Topics: Angioplasty, Balloon, Coronary; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Suction; Tirofiban; Tyrosine	2008
Successful treatment of cardiogenic shock by stenting of the left main coronary artery in acute myocardial infarction. Vojnosanitetski pregled, 2008, Volume: 65, Issue:10 Topics: Coronary Vessels; Electrocardiography; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Stents; Thrombolytic Therapy; Tirofiban; Tyrosine	2008
Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Feb-01, Volume: 73, Issue:2 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Artery Disease; Eptifibatide; Female; Hemorrhage; Hospital Mortality; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Stents; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2009
The benefits and risks of abciximab, eptifibatide, or tirofiban during PCI: class effects or do they differ? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Feb-01, Volume: 73, Issue:2 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Artery Disease; Eptifibatide; Hemorrhage; Hospital Mortality; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Risk Assessment; Stents; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2009
Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female. Clinical cardiology, 2009, Volume: 32, Issue:2 Topics: Adult; Age Factors; Antisickling Agents; Aspirin; Clopidogrel; Coronary Angiography; Female; Fibrinolytic Agents; Heparin; Humans; Hydroxyurea; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombocythemia, Essential; Ticlopidine; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2009
The opposite roles of nNOS in cardiac ischemia-reperfusion-induced injury and in ischemia preconditioning-induced cardioprotection in mice. The journal of physiological sciences : JPS, 2009, Volume: 59, Issue:4 Topics: Animals; Apoptosis; Enzyme Inhibitors; Free Radical Scavengers; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Metalloporphyrins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase Type I; Ornithine; Oxidative Stress; Reactive Nitrogen Species; Thiobarbituric Acid Reactive Substances; Tyrosine	2009
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? Journal of the American College of Cardiology, 2009, May-05, Volume: 53, Issue:18 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2009
Acute inferior myocardial infarction due to cannabis smoking in a young man. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:9 Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Fibrinolytic Agents; Humans; Male; Marijuana Smoking; Myocardial Infarction; Stents; Tirofiban; Treatment Outcome; Tyrosine	2009
[MULTISTRATEGY and FATA: merits, limits and troubles of no profit clinical trials in acute myocardial infarction]. Giornale italiano di cardiologia (2006), 2009, Volume: 10, Issue:6 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Humans; Immunoglobulin Fab Fragments; Italy; Myocardial Infarction; Platelet Aggregation Inhibitors; Survival Analysis; Tirofiban; Tyrosine	2009
Oxidative damage markers and antioxidants in patients with acute myocardial infarction and their clinical significance. BioFactors (Oxford, England), 2008, Volume: 34, Issue:2 Topics: Antioxidants; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Peroxidase; Tyrosine	2008
Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5 Topics: Animals; Biomarkers; Cholesterol, Dietary; Disease Models, Animal; Hyperlipidemias; Male; Metalloporphyrins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peroxynitrous Acid; Rats; Signal Transduction; Stress, Physiological; Tyrosine	2009
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction. Free radical biology & medicine, 2010, Jan-15, Volume: 48, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine	2010
A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580. The Journal of biological chemistry, 2010, Jan-29, Volume: 285, Issue:5 Topics: Animals; Enzyme Activation; Humans; Imidazoles; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Models, Biological; Myocardial Infarction; Myocardial Ischemia; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Isoforms; Pyridines; Tyrosine	2010
Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. American journal of physiology. Endocrinology and metabolism, 2010, Volume: 298, Issue:4 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Creatine Kinase; Electrocardiography; Heart Function Tests; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Reperfusion Injury; Tyrosine	2010
Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction. Biochemistry, 2010, Mar-23, Volume: 49, Issue:11 Topics: Amino Acid Sequence; Animals; Cell Hypoxia; Cyclic N-Oxides; Cysteine; Disulfides; Electron Transport Complex II; Flavin-Adenine Dinucleotide; Humans; Molecular Sequence Data; Molecular Weight; Muscle Cells; Myocardial Infarction; Oxidation-Reduction; Peroxynitrous Acid; Protein Subunits; Rats; Rats, Sprague-Dawley; Tyrosine	2010
Vanishing platelets: rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction. Texas Heart Institute journal, 2010, Volume: 37, Issue:1 Topics: Angioplasty, Balloon, Coronary; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Renal Insufficiency; Severity of Illness Index; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2010
TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovascular research, 2010, Sep-01, Volume: 87, Issue:4 Topics: Animals; Cardiotonic Agents; Cell Line; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Ligands; Lipopeptides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; Peptidoglycan; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Time Factors; Toll-Like Receptor 2; Tyrosine; Ventricular Function	2010
IIb or Not IIb: is there a place for pre-hospital tirofiban in ST-segment elevation myocardial infarction patients? Journal of the American College of Cardiology, 2010, Jun-01, Volume: 55, Issue:22 Topics: Angioplasty, Balloon, Coronary; Electrocardiography; Emergency Medical Services; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Pulse Therapy, Drug; Risk Assessment; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2010
Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2010, Volume: 10, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Creatine Kinase; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Myocardial Infarction; Retrospective Studies; Stroke Volume; Tirofiban; Treatment Outcome; Tyrosine	2010
Pharmacoinvasive strategy for ST-segment elevation myocardial infarction: wading through the treatment options. Circulation. Cardiovascular interventions, 2010, Volume: 3, Issue:4 Topics: Angioplasty; Anticoagulants; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine; Ultrasonography	2010
Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2011, Volume: 17, Issue:5 Topics: Electrocardiography; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine	2011
Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovascular research, 2011, Feb-15, Volume: 89, Issue:3 Topics: Animals; Apoptosis; Cells, Cultured; HMGB1 Protein; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myoblasts, Cardiac; Myocardial Infarction; Necrosis; Peroxynitrous Acid; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Toll-Like Receptor 4; Tyrosine; Up-Regulation	2011
Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:1 Topics: Anilides; Animals; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxazoles; PPAR alpha; PPAR gamma; Prostaglandin D2; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine	2011
[Efficiency and safety of thrombus aspiration plus intra-infarct-related artery administration of tirofiban during primary angioplasty]. Zhonghua xin xue guan bing za zhi, 2010, Volume: 38, Issue:10 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Tirofiban; Tyrosine	2010
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolim JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Angiography; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2011
Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts. Free radical biology & medicine, 2011, Jun-01, Volume: 50, Issue:11 Topics: Acetophenones; Allopurinol; Animals; Arrhythmias, Cardiac; Coronary Vessels; Ethidium; Male; Molsidomine; Myocardial Infarction; Myocardium; NADPH Oxidases; Nerve Growth Factor; Oxidative Stress; Peroxynitrous Acid; Rats; Rats, Wistar; Superoxides; Sympathetic Nervous System; Tyrosine; Xanthine Oxidase	2011
Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:5 Topics: Animals; Cholesterol; Cholesterol, Dietary; Connexin 43; Hyperlipidemias; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Models, Animal; Myocardial Infarction; Rats; Rats, Wistar; Sarcolemma; Superoxides; Tyrosine	2011
Cannabis: a rare trigger of premature myocardial infarction. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2011, Volume: 11, Issue:3 Topics: Adult; Angioplasty, Balloon, Coronary; Electrocardiography; Fibrinolytic Agents; Humans; Male; Marijuana Smoking; Myocardial Infarction; Risk Factors; Smoking; Stents; Time Factors; Tirofiban; Tyrosine	2011
Controversies with On-TIME 2. Heart (British Cardiac Society), 2011, Volume: 97, Issue:12 Topics: Emergency Medical Services; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Treatment Outcome; Tyrosine	2011
Position of tirofiban in ST segment elevation myocardial infarction treatment: more than an adjunctive therapy. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:5 Topics: Adult; Aged; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Tirofiban; Tyrosine	2011
AMI on the move. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7, Issue:4 Topics: Accelerated Idioventricular Rhythm; Ambulances; Angioplasty, Balloon, Coronary; Coronary Occlusion; Delivery of Health Care, Integrated; Electrocardiography; Emergency Medical Services; Female; Fibrinolytic Agents; Gene Expression Profiling; Health Services Accessibility; Hemodynamics; Humans; Male; Myocardial Infarction; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; RNA, Messenger; Telemetry; Tirofiban; Transcription, Genetic; Tyrosine	2011
Investigating the effect of antioxidant treatment on the protective effect of preconditioning in anesthetized rabbits. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:6 Topics: Animals; Antioxidants; Glutathione; Infusions, Intravenous; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Male; Myocardial Infarction; Oxidative Stress; Rabbits; Time Factors; Tiopronin; Tyrosine	2011
Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:5 Topics: Administration, Oral; Angiogenesis Inducing Agents; Animals; Biopterins; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; GTP Cyclohydrolase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pterins; Recovery of Function; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Ventricular Function, Left	2011
A lipophilic nitric oxide donor and a lipophilic antioxidant compound protect rat heart against ischemia-reperfusion injury if given as hybrid molecule but not as a mixture. Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:3 Topics: Animals; Antioxidants; Cardiotonic Agents; Drug Synergism; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Wistar; Tyrosine	2012
IC bolus only versus IV with infusion 2b/3a inhibitors during STEMIs having PCI. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Jan-01, Volume: 79, Issue:1 Topics: Angioplasty, Balloon, Coronary; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2012
Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2012, Volume: 12, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Cohort Studies; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Severity of Illness Index; Tirofiban; Tyrosine	2012
Direct intracoronary delivery of tirofiban during primary percutaneous coronary intervention for ST-elevation myocardial infarction. Chinese medical journal, 2012, Volume: 125, Issue:1 Topics: Angioplasty, Balloon, Coronary; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2012
Evaluation of multimeric tyrosine-O-sulfate as a cytoprotectant in an in vivo model of acute myocardial infarction in pigs. Cardiology, 2012, Volume: 121, Issue:1 Topics: Animals; Anticoagulants; Complement Inactivating Agents; Complement Pathway, Classical; Cytoprotection; Dose-Response Relationship, Drug; Granulocytes; Hemodynamics; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Neutrophils; Sus scrofa; Thromboplastin; Tyrosine; Ventricular Fibrillation	2012
The illusion of "optimal" platelet inhibition. JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:3 Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Blood Platelets; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Male; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Thiophenes; Tirofiban; Tyrosine	2012
Upstream glycoprotein IIb/IIIa inhibitors for STEMI: use on-time or not at all? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, May-01, Volume: 79, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Emergency Medical Services; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2012
Acute myocardial infarction during the early postpartum period successfully treated with tirofiban. European review for medical and pharmacological sciences, 2012, Volume: 16 Suppl 1 Topics: Acute Disease; Adult; Coronary Angiography; Electrocardiography; Heart Valve Prosthesis; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Platelet Aggregation Inhibitors; Postpartum Period; Thrombosis; Tirofiban; Tyrosine	2012
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors. The Journal of invasive cardiology, 2012, Volume: 24, Issue:7 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Electrocardiography; Eptifibatide; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Regional Blood Flow; Regression Analysis; Retrospective Studies; Risk Factors; Survival Rate; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine	2012
Acute myocardial infarction secondary to blunt chest trauma treated with thrombus aspiration. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2012, Oct-23, Volume: 12, Issue:7 Topics: Adult; Cardiac Catheterization; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Thoracic Injuries; Tirofiban; Tyrosine; Wounds, Nonpenetrating	2012
Preconditioning protects the heart in a prolonged uremic condition. American journal of physiology. Heart and circulatory physiology, 2012, Nov-15, Volume: 303, Issue:10 Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Urea; Uremia; Uric Acid; Ventricular Function, Left	2012
Management of myocardial infarction related to in situ thrombosis. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2013, Volume: 13, Issue:2 Topics: Angina Pectoris; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Myocardial Infarction; Thrombectomy; Tirofiban; Tyrosine	2013
Chronic Tempol treatment restores pharmacological preconditioning in the senescent rat heart. American journal of physiology. Heart and circulatory physiology, 2013, Mar-01, Volume: 304, Issue:5 Topics: Aging; Animals; Antioxidants; Calcium; Cardiotonic Agents; Cyclic N-Oxides; Heart; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Mitochondria; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Inbred F344; Spin Labels; Superoxide Dismutase; Tyrosine	2013
Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult. Pharmaceutical biology, 2013, Volume: 51, Issue:4 Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Down-Regulation; Enzyme Activation; Free Radical Scavengers; Injections, Intraperitoneal; Iridoid Glucosides; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine	2013
[Platelet antiaggregation treatment in the aftermath of GUSTO IV, TARGET, TACTICS, and CURE trials]. Revista espanola de cardiologia, 2002, Volume: 55, Issue:7 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Bypass; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Time Factors; Tirofiban; Tyrosine	2002
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidel Circulation, 2002, Oct-01, Volume: 106, Issue:14 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Biomarkers; Clopidogrel; Disease Management; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Female; Health Behavior; Hemorrhage; Humans; Hypolipidemic Agents; Immunoglobulin Fab Fragments; Male; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Ticlopidine; Tirofiban; Tyrosine	2002
Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy. The American journal of cardiology, 2003, Feb-15, Volume: 91, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Coronary Disease; Electrocardiography; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; Patient Selection; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Risk Factors; Safety; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2003
Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1 Topics: Animals; Chronic Disease; Collagen; Disease Models, Animal; DNA; Enzyme Inhibitors; Fibroblasts; Heart Failure; Hemodynamics; Ligation; Male; Mesylates; Myocardial Infarction; Myocardium; Neprilysin; Organ Size; Peptide Hydrolases; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Tyrosine; Ventricular Remodeling	2003
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Jun-15, Volume: 60, Issue:12 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Case-Control Studies; Drug Costs; Eptifibatide; Female; Hospital Costs; Hospital Mortality; Humans; Immunoglobulin Fab Fragments; Length of Stay; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine; United States	2003
Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology, 2003, Volume: 99, Issue:2 Topics: Anesthetics; Anesthetics, Inhalation; Animals; Blood Pressure; Coronary Circulation; Electrophysiology; Enzyme Activation; Ethidium; Fluorescent Dyes; Guinea Pigs; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoenzymes; Methyl Ethers; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C-delta; Protein Kinase C-epsilon; Reactive Oxygen Species; Sevoflurane; Signal Transduction; Tyrosine; Ventricular Function, Left	2003
Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:10 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Tirofiban; Treatment Outcome; Tyrosine	2003
Evidence of platelet activation due to tirofiban-dependent platelet antibodies: double trouble. Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:10 Topics: Aged; Antibodies; Blood Platelets; Flow Cytometry; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Serotonin; Thrombocytopenia; Time Factors; Tirofiban; Tyrosine	2003
Platelet inhibition strategies in percutaneous coronary intervention: competition or coopetition? Journal of the American College of Cardiology, 2003, Oct-01, Volume: 42, Issue:7 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Administration Schedule; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Tyrosine	2003
Beta brachytherapy of an old degenerated saphenous vein graft with occlusive in-stent restenosis. Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Beta Particles; Blood Vessel Prosthesis; Brachytherapy; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Myocardial Infarction; Phosphorus Radioisotopes; Reoperation; Saphenous Vein; Stents; Ticlopidine; Tirofiban; Tyrosine	2003
Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. The American journal of cardiology, 2003, Dec-01, Volume: 92, Issue:11 Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Statistics, Nonparametric; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine	2003
Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. Journal of the American College of Cardiology, 2004, Jan-21, Volume: 43, Issue:2 Topics: Animals; Coronary Circulation; Dogs; Echocardiography; Microcirculation; Models, Animal; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Tirofiban; Tyrosine	2004
Glycoprotein IIb/IIIa inhibitors and no-reflow. Journal of the American College of Cardiology, 2004, Jan-21, Volume: 43, Issue:2 Topics: Animals; Coronary Circulation; Fibrinolytic Agents; Humans; Microcirculation; Models, Animal; Myocardial Infarction; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thrombosis; Tirofiban; Tyrosine; Vascular Patency	2004
Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes, 2004, Volume: 53, Issue:2 Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Hyperglycemia; Insulin; Interleukins; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Reference Values; RNA; Streptozocin; Tyrosine	2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and th Circulation, 2004, Feb-24, Volume: 109, Issue:7 Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Comorbidity; Coronary Disease; Female; Hospitalization; Humans; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Stents; Survival Analysis; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine	2004
Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome. Heart (British Cardiac Society), 2004, Volume: 90, Issue:3 Topics: Angina, Unstable; Diagnostic Errors; Fatal Outcome; Hemorrhage; Humans; Lung Diseases; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Edema; Radiography; Tirofiban; Tyrosine	2004
Effect of adjunctive tirofiban therapy on angiographic and clinical outcomes in patients with ST-segment elevated acute myocardial infarction undergoing primary stenting. Japanese heart journal, 2004, Volume: 45, Issue:1 Topics: Aged; Coronary Angiography; Coronary Circulation; Electrocardiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Stents; Tirofiban; Treatment Outcome; Tyrosine	2004
Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2004, Volume: 10, Issue:1 Topics: Female; Humans; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocythemia, Essential; Tirofiban; Treatment Outcome; Tyrosine	2004
The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3 Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Rate; Male; Membrane Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channels; Protein Tyrosine Phosphatases; Pyrones; Rats; Rats, Wistar; Time Factors; Tyrosine; Vanadates	2004
Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation, 2004, May-04, Volume: 109, Issue:17 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Circulation; Female; Heart Ventricles; Heparin; Humans; Immunoglobulin Fab Fragments; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Prospective Studies; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Function, Left	2004
Tirofiban for catheter intervention in acute myocardial infarction? European heart journal, 2004, Volume: 25, Issue:10 Topics: Angioplasty, Balloon, Coronary; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2004
Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase. Zeitschrift fur Kardiologie, 2004, Volume: 93, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recovery of Function; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine	2004
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. The American journal of cardiology, 2004, Jun-01, Volume: 93, Issue:11 Topics: Abciximab; Antibodies, Monoclonal; Clinical Trials, Phase II as Topic; Cohort Studies; Coronary Angiography; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Tenecteplase; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2004
Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study. Journal of thrombosis and thrombolysis, 2004, Volume: 17, Issue:2 Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Vessels; Drug Administration Schedule; Feasibility Studies; Heparin; Humans; Myocardial Infarction; Pilot Projects; Prospective Studies; Regional Blood Flow; Statistics, Nonparametric; Time Factors; Tirofiban; Tyrosine	2004
Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation, 2004, Sep-14, Volume: 110, Issue:11 Topics: Abciximab; Adenosine Diphosphate; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiovascular Agents; Clopidogrel; Collagen; Comorbidity; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Ticlopidine; Tirofiban; Tyrosine; von Willebrand Factor	2004
Impact of invasive strategy for the management of patients with cardiogenic shock after acute myocardial infarction. Coronary artery disease, 2004, Volume: 15, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Chemotherapy, Adjuvant; Coronary Artery Bypass; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Risk Factors; Shock, Cardiogenic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Tyrosine	2004
Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction. The American journal of cardiology, 2004, Dec-15, Volume: 94, Issue:12 Topics: Angina, Unstable; Aspirin; Exercise Test; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Safety; Tirofiban; Tyrosine	2004
[Spleen rupture in myocardial infarction after administration of GP IIb-IIIa-antagonists]. Deutsche medizinische Wochenschrift (1946), 2005, Jan-07, Volume: 130, Issue:1-2 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Echocardiography; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Splenectomy; Splenic Rupture; Stents; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine	2005
Safety of tirofiban therapy in very old patients with acute coronary syndrome or non-Q-wave myocardial infarction. Journal of the American Geriatrics Society, 2005, Volume: 53, Issue:1 Topics: Aged; Aged, 80 and over; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Risk Factors; Tirofiban; Tyrosine	2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). The American journal of cardiology, 2005, Mar-01, Volume: 95, Issue:5 Topics: Abciximab; Acetates; Aged; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Streptokinase; Survival Analysis; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine	2005
Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:6 Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Administration Schedule; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine	2004
Combination of a high bolus dose of tirofiban with half-dose thrombolytics for the treatment of subacute stent thrombosis. Acta cardiologica, 2005, Volume: 60, Issue:1 Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Myocardial Infarction; Risk Assessment; Stents; Tirofiban; Tyrosine; Vascular Patency	2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 2005, Apr-05, Volume: 45, Issue:7 Topics: Angioplasty, Balloon, Coronary; Blood Glucose; Case-Control Studies; Coronary Circulation; Female; Humans; Hyperglycemia; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Preoperative Care; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine	2005
Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study. International journal of cardiology, 2005, Apr-08, Volume: 100, Issue:1 Topics: Aged; Angina, Unstable; Anticoagulants; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Syndrome; Tirofiban; Tyrosine	2005
Delayed tirofiban-induced thrombocytopenia: two case reports. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:5 Topics: Aged; Aged, 80 and over; Antibodies; Anticoagulants; Blood Platelets; Echocardiography; Enzyme-Linked Immunosorbent Assay; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Thrombocytopenia; Time Factors; Tirofiban; Tyrosine	2005
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thrombosis and haemostasis, 2005, Volume: 93, Issue:5 Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Female; Fibrinolytic Agents; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Stroke; Time Factors; Tirofiban; Tyrosine	2005
Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty. Cardiovascular research, 2005, Jun-01, Volume: 66, Issue:3 Topics: Acute Disease; Angioplasty, Balloon, Coronary; Animals; Coronary Thrombosis; Dogs; Integrin alphaVbeta3; Male; Models, Animal; Myocardial Infarction; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrimidines; Random Allocation; Tirofiban; Tyrosine	2005
Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in? Pharmacy world & science : PWS, 2005, Volume: 27, Issue:2 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cost-Benefit Analysis; Diabetes Mellitus; Drug Costs; Eptifibatide; Hospital Costs; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2005
Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. The Journal of invasive cardiology, 2005, Volume: 17, Issue:6 Topics: Abciximab; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Chemotherapy, Adjuvant; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2005
Comparison of abciximab with "high-dose" tirofiban in patients undergoing percutaneous coronary intervention. International journal of cardiology, 2006, Apr-28, Volume: 109, Issue:1 Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Australia; Diabetic Angiopathies; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Syndrome; Tirofiban; Troponin; Tyrosine	2006
Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI. International journal of cardiology, 2005, Aug-18, Volume: 103, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Creatine Kinase; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Conduction System; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Preoperative Care; Recombinant Proteins; Research Design; Streptokinase; Tenecteplase; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine	2005
Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:1 Topics: Animals; Blotting, Western; Cholesterol, Dietary; Diet; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxamic Acids; Hyperlipidemias; Indoles; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase Inhibitors; Myocardial Infarction; Myocardium; Protease Inhibitors; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Tyrosine	2006
Tirofiban plus sirolimus-eluting stent vs abciximab plus bare-metal stent. JAMA, 2005, Oct-05, Volume: 294, Issue:13 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Drug Delivery Systems; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sirolimus; Stents; Tirofiban; Tyrosine	2005
Tirofiban plus sirolimus-eluting stent vs abciximab plus bare-metal stent. JAMA, 2005, Oct-05, Volume: 294, Issue:13 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Drug Delivery Systems; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sirolimus; Stents; Thrombectomy; Tirofiban; Tyrosine	2005
[Effects of anti-platelet drugs on myocardial no-reflow after acute myocardial infarction and reperfusion: experiment with mini-swine model]. Zhonghua yi xue za zhi, 2005, Aug-17, Volume: 85, Issue:31 Topics: Animals; Clopidogrel; Coronary Circulation; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Random Allocation; Swine; Swine, Miniature; Thrombolytic Therapy; Ticlopidine; Tirofiban; Tyrosine	2005
Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion. Heart (British Cardiac Society), 2006, Volume: 92, Issue:8 Topics: Animals; Aspirin; Clopidogrel; Coronary Circulation; Drug Therapy, Combination; Myocardial Infarction; Myocardial Reperfusion; Nitric Oxide; Nitric Oxide Synthase; Platelet Aggregation Inhibitors; Random Allocation; Swine; Swine, Miniature; Ticlopidine; Tirofiban; Tyrosine	2006
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis. Journal of the American College of Cardiology, 2006, Feb-07, Volume: 47, Issue:3 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Life Expectancy; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Quality-Adjusted Life Years; Risk Assessment; Risk Factors; Tirofiban; Tyrosine	2006
Upstream/downstream glycoprotein IIb/IIIa in non-ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 2006, Feb-07, Volume: 47, Issue:3 Topics: Abciximab; Antibodies, Monoclonal; Cost-Benefit Analysis; Drug Costs; Electrocardiography; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2006
Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty. Cardiology, 2006, Volume: 105, Issue:3 Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Echocardiography; Electrocardiography; Female; Fibrinolytic Agents; Heart Conduction System; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Reproducibility of Results; Research Design; Retrospective Studies; Stents; Stroke Volume; Tirofiban; Treatment Outcome; Tyrosine	2006
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine	2006
Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:2 Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Blotting, Western; C-Reactive Protein; Heart; Immunohistochemistry; In Situ Nick-End Labeling; Isoproterenol; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; RNA; Stress, Physiological; Tyrosine	2006
A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. Journal of the American College of Cardiology, 2006, Apr-18, Volume: 47, Issue:8 Topics: Aged; Cholesterol; Complement Factor H; Diabetes Complications; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Histidine; Homozygote; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Proportional Hazards Models; Risk Factors; Smoking; Tyrosine	2006
Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome. Journal of cardiovascular medicine (Hagerstown, Md.), 2006, Volume: 7, Issue:3 Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Angiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Registries; Stents; Syndrome; Tirofiban; Tyrosine	2006
Acute coronary embolism after mitral valve replacement in a patient presenting with non-ST-segment elevation myocardial infarction. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2006, Volume: 6, Issue:2 Topics: Adult; Angina Pectoris; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Fibrinolytic Agents; Heart Conduction System; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2006
Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation, 2006, Sep-26, Volume: 114, Issue:13 Topics: Acute Disease; Adult; Angina, Unstable; Blood Transfusion; Cerebral Hemorrhage; Creatinine; Disease Susceptibility; Dose-Response Relationship, Drug; Eptifibatide; Glomerular Filtration Rate; Hemorrhage; Hemorrhagic Disorders; Humans; Kidney Diseases; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Registries; Sex Characteristics; Tirofiban; Tyrosine	2006
[Platelet function after a high dose bolus of tirofiban immediately after coronary angioplasty]. Archives des maladies du coeur et des vaisseaux, 2006, Volume: 99, Issue:10 Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Syndrome; Time Factors; Tirofiban; Tyrosine	2006
Time-dependent expression pattern of nitric oxide and superoxide after myocardial infarction in rats. Pharmacological research, 2007, Volume: 55, Issue:1 Topics: Animals; Enzyme Activation; Immunohistochemistry; Kinetics; Male; Myocardial Infarction; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peroxynitrous Acid; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxides; Time Factors; Tyrosine	2007
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. Journal of the American College of Cardiology, 2006, Dec-05, Volume: 48, Issue:11 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; Coronary Angiography; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Randomized Controlled Trials as Topic; Stents; Time Factors; Tirofiban; Treatment Outcome; Troponin I; Tyrosine	2006
Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results. The Journal of invasive cardiology, 2007, Volume: 19, Issue:2 Topics: Abciximab; Aged; Antibodies, Monoclonal; Anticoagulants; Coronary Artery Disease; Costs and Cost Analysis; Drug Delivery Systems; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Length of Stay; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Sirolimus; Stents; Tirofiban; Treatment Outcome; Tyrosine	2007
Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation, 2007, Mar-20, Volume: 115, Issue:11 Topics: Adiponectin; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxynitrous Acid; Reactive Nitrogen Species; Superoxides; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation	2007
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). The American journal of cardiology, 2007, May-15, Volume: 99, Issue:10 Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Eptifibatide; Female; Hospital Mortality; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; United States	2007
Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. Journal of the American College of Cardiology, 2007, May-22, Volume: 49, Issue:20 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; New Zealand; Peroxidase; Prognosis; Proportional Hazards Models; Protein Carbonylation; Radionuclide Imaging; Retrospective Studies; Sex Factors; Stroke Volume; Tyrosine; Ventricular Dysfunction, Left	2007
Ischemic preconditioning prevents in vivo hyperoxygenation in postischemic myocardium with preservation of mitochondrial oxygen consumption. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:3 Topics: Animals; Coronary Vessels; Cytochromes c; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Infarction; Myocardium; NADH Dehydrogenase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Oxygen Consumption; Random Allocation; Reactive Oxygen Species; Regional Blood Flow; Tyrosine	2007
Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Animals; Arrhythmias, Cardiac; Calcium; Coronary Circulation; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Fluorescent Dyes; Free Radicals; Heterocyclic Compounds, 3-Ring; Immunohistochemistry; Isoenzymes; Mice; Mice, Transgenic; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spectrometry, Fluorescence; Time Factors; Tyrosine; Ventricular Function, Left; Ventricular Pressure	2007
Treatment of acute myocardial infarction in pregnancy with coronary artery balloon angioplasty and stenting: use of tirofiban and clopidogrel. International journal of cardiology, 2008, Jul-21, Volume: 127, Issue:3 Topics: Adult; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Myocardial Infarction; Pregnancy; Pregnancy Complications, Cardiovascular; Ticlopidine; Tirofiban; Tyrosine	2008
Pulmonary hemorrhage in a patient with acute coronary syndrome. AJR. American journal of roentgenology, 2007, Volume: 189, Issue:3 Topics: Aged; Angina, Unstable; Hemorrhage; Humans; Lung Diseases; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Radiography; Tirofiban; Tyrosine	2007
STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction. Circulation research, 2007, Oct-26, Volume: 101, Issue:9 Topics: Animals; Biomarkers; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Butadienes; Capillaries; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Drug Synergism; Embryonic Stem Cells; Enzyme Inhibitors; Leukemia Inhibitory Factor; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocytes, Cardiac; Nitriles; Phosphorylation; Serine; Signal Transduction; STAT3 Transcription Factor; Stem Cell Transplantation; Transforming Growth Factor beta; Triterpenes; Tyrosine	2007
Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2 Topics: Animals; Apoptosis; Cardiac Catheterization; Cardiomegaly; Echocardiography; Fibrosis; Matrix Metalloproteinase 2; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardial Infarction; Myocardium; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; RNA, Messenger; Staining and Labeling; Survival Analysis; Tyrosine; Ventricular Remodeling	2008
High-dose tirofiban administered as bolus-only during percutaneous coronary intervention. The Journal of invasive cardiology, 2008, Volume: 20, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Eptifibatide; Female; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Retrospective Studies; Tirofiban; Treatment Outcome; Tyrosine	2008
Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction. Clinical biochemistry, 2008, Volume: 41, Issue:7-8 Topics: Acute Disease; Aged; Biomarkers; Female; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Peroxidase; Sensitivity and Specificity; Taiwan; Tyrosine	2008
Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo. Journal of the American College of Cardiology, 1983, Volume: 2, Issue:4 Topics: Animals; Antipain; Cathepsins; Cell Survival; Chymotrypsin; Endopeptidases; Heart; Leupeptins; Male; Myocardial Infarction; Myocardium; Oligopeptides; Pepstatins; Protease Inhibitors; Rats; Rats, Inbred Strains; Time Factors; Tyrosine	1983
[Level of tyrosine in the blood of patients with acute myocardial infarction during the assessment of corticosteroid hormone production]. Kardiologiia, 1983, Volume: 23, Issue:7 Topics: 11-Hydroxycorticosteroids; Adrenal Cortex; Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Tyrosine	1983
Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circulation research, 1993, Volume: 73, Issue:3 Topics: Animals; Antioxidants; Coronary Circulation; Dogs; Female; Hydroxides; Hydroxyl Radical; Hydroxylation; Male; Myocardial Infarction; Myocardium; Phenylalanine; Tyrosine	1993
[Superaspirin in the platelet aggregation inhibitor therapy]. Recenti progressi in medicina, 1997, Volume: 88, Issue:12 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine	1997
Survival analysis with uncertain endpoints. Biometrics, 1998, Volume: 54, Issue:1 Topics: Angioplasty, Balloon; Biometry; Clinical Trials as Topic; Computer Simulation; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Tirofiban; Tyrosine	1998
Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease. The New England journal of medicine, 1998, May-21, Volume: 338, Issue:21 Topics: Angina, Unstable; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	1998
Tirofiban in unstable coronary disease. The New England journal of medicine, 1998, Oct-15, Volume: 339, Issue:16 Topics: Angina, Unstable; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Tirofiban; Tyrosine	1998
GP IIb/IIIa inhibitors: an evidence-based approach to their use. Medical management network, 1999, Volume: 7, Issue:3 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Cost-Benefit Analysis; Disease Management; Drug Costs; Eptifibatide; Evidence-Based Medicine; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine; United States	1999
Cost-effective treatment of acute coronary syndromes-IIB or not IIB? European heart journal, 1999, Volume: 20, Issue:17 Topics: Angina, Unstable; Cost-Benefit Analysis; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Switzerland; Tirofiban; Tyrosine	1999
Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting: an analysis based on the PRISM PLUS trial. European heart journal, 1999, Volume: 20, Issue:17 Topics: Angina, Unstable; Cost of Illness; Cost-Benefit Analysis; Fibrinolytic Agents; Heparin; Hospitalization; Humans; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Switzerland; Tirofiban; Tyrosine	1999
Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors. Connecticut medicine, 1999, Volume: 63, Issue:8 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine	1999
A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. American heart journal, 1999, Volume: 138, Issue:4 Pt 2 Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Tirofiban; Tyrosine	1999
[GP-IIb/IIIa antagonists expand the anti thrombotic therapy of acute coronary syndromes. Satellite symposium during the 21st Congress of the European Society of Cardiology. Barcelona, August 1999]. Deutsche medizinische Wochenschrift (1946), 1999, Dec-03, Volume: 124, Issue:48 Suppl Topics: Acute Disease; Coronary Disease; Drug Combinations; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Thrombolytic Therapy; Tirofiban; Tyrosine	1999
Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction. Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:1 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; DNA-Binding Proteins; Heart Ventricles; Hemodynamics; Imidazoles; Imidazolidines; Male; Myocardial Infarction; Organ Size; Phosphorylation; Rats; Rats, Wistar; Sp1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Trans-Activators; Tyrosine	2000
Tirofiban and intracoronary stenting: evaluation of a new pharmacologic regimen. The Journal of invasive cardiology, 1999, Volume: 11, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents; Tirofiban; Tyrosine	1999
IIb's are not IIb's. The American journal of cardiology, 2000, Apr-27, Volume: 85, Issue:8A Topics: Abciximab; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine; Vitronectin	2000
The role of tirofiban in acute coronary syndromes. International journal of clinical practice, 2000, Volume: 54, Issue:2 Topics: Angina, Unstable; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Tyrosine	2000
What have We learned from ESPRIT? What will we learn from TARGET? The Journal of invasive cardiology, 2000, Volume: 12, Issue:6 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Cohort Studies; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Ticlopidine; Tirofiban; Tyrosine	2000
Physiological effects of peroxynitrite: potential products of the environment. Circulation research, 2000, Aug-04, Volume: 87, Issue:3 Topics: Animals; Blood Physiological Phenomena; Cats; Crystalloid Solutions; Cytokines; Glutathione; Heart; Heart Diseases; Heart Ventricles; Humans; Isotonic Solutions; Myocardial Infarction; Nitrates; Nitric Oxide; Perfusion; Plasma Substitutes; Superoxides; Tyrosine	2000
Drip and ship: a new strategy for the treatment of acute coronary syndromes. Journal of thrombosis and thrombolysis, 2000, Volume: 10, Issue:1 Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Protocols; Coronary Angiography; Coronary Disease; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Hospitalization; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine	2000
Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. The American journal of cardiology, 2000, Oct-01, Volume: 86, Issue:7 Topics: Angina, Unstable; Anticoagulants; Coronary Disease; Creatine Kinase; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heart Failure; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Regression Analysis; Risk Factors; Statistics, Nonparametric; Tirofiban; Treatment Outcome; Troponin I; Tyrosine	2000
Tirofiban counteracts pending myocardial infarction. Journal of internal medicine, 2000, Volume: 248, Issue:4 Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Drug Monitoring; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	2000
[Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists]. Medicina clinica, 2000, Oct-07, Volume: 115, Issue:11 Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Atherectomy; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine; United States; United States Food and Drug Administration	2000
Fast, aggressive treatment for myocardial infarction urged. JAMA, 2000, Dec-20, Volume: 284, Issue:23 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; Coronary Artery Bypass; Heptanoic Acids; Humans; Hypolipidemic Agents; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Stents; Tirofiban; Tyrosine	2000
[New thrombocyte aggregation inhibitor in therapy of unstable angina]. Zeitschrift fur Kardiologie, 2000, Volume: 89, Issue:11 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine	2000
Complicated acute myocardial infarction. The Journal of emergency medicine, 2001, Volume: 20, Issue:1 Topics: Electrocardiography; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Retrobulbar Hemorrhage; Tirofiban; Tomography, X-Ray Computed; Tyrosine	2001
Role of tirofiban in the medical treatment of the intermediate-risk patient with an acute coronary syndrome cannot be denied. The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Confidence Intervals; Coronary Angiography; Double-Blind Method; Fibrinolytic Agents; Heparin; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Tirofiban; Treatment Outcome; Tyrosine	2000
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. European journal of clinical investigation, 2001, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aspartic Acid; Brain Infarction; Cardiovascular Diseases; Case-Control Studies; Cysteine; Female; France; Genetic Predisposition to Disease; Genotype; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Myocardial Infarction; Northern Ireland; Polymorphism, Genetic; Prevalence; Prospective Studies; Tyrosine; Ultrasonography; United Kingdom	2001
Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors? Lancet (London, England), 2001, May-12, Volume: 357, Issue:9267 Topics: Aged; Angina, Unstable; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematoma; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Streptokinase; Thrombolytic Therapy; Tirofiban; Tyrosine	2001
Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation, 2001, Aug-07, Volume: 104, Issue:6 Topics: Animals; Female; Gene Expression Regulation, Enzymologic; Genotype; Heart Ventricles; Hemodynamics; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Contraction; Myocardial Infarction; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; RNA, Messenger; Survival Rate; Time Factors; Tyrosine	2001
Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation, 2001, Aug-28, Volume: 104, Issue:9 Topics: Animals; Blotting, Northern; Blotting, Western; Collagen; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Contraction; Myocardial Infarction; Myosin Heavy Chains; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pyridines; Rats; Rats, Wistar; RNA, Messenger; Tyrosine	2001
Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction. The Journal of invasive cardiology, 2001, Volume: 13, Issue:9 Topics: Adult; Angioplasty, Balloon; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2001
[Antithrombotic therapy of unstable angina pectoris]. Duodecim; laaketieteellinen aikakauskirja, 1998, Volume: 114, Issue:15 Topics: Angina, Unstable; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Ticlopidine; Tirofiban; Tyrosine	1998
Eptifibatide and tirofiban: new preparations. Limited benefit. Prescrire international, 2000, Volume: 9, Issue:49 Topics: Angina Pectoris; Antibodies, Monoclonal; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Risk Factors; Treatment Outcome; Tyrosine	2000
A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria. The American journal of cardiology, 2001, Dec-01, Volume: 88, Issue:11 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Creatine Kinase; Creatine Kinase, MB Form; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Tirofiban; Tyrosine	2001
Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes. Lancet (London, England), 2001, Dec-08, Volume: 358, Issue:9297 Topics: Abciximab; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Survival Analysis; Tirofiban; Treatment Outcome; Troponin T; Tyrosine	2001
Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs. Journal of the American College of Cardiology, 2002, Jan-02, Volume: 39, Issue:1 Topics: Acetates; Animals; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Neutrophils; Peroxidase; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; Tyrosine	2002
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. The New England journal of medicine, 2001, Nov-22, Volume: 345, Issue:21 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2001
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. The New England journal of medicine, 2001, Nov-22, Volume: 345, Issue:21 Topics: Angioplasty, Balloon, Coronary; Bias; Combined Modality Therapy; Creatine Kinase; Creatine Kinase, MB Form; Humans; Isoenzymes; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2001
Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:3 Topics: Animals; Apoptosis; Cardiotonic Agents; Cytokines; HSP70 Heat-Shock Proteins; JNK Mitogen-Activated Protein Kinases; Kinetics; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Signal Transduction; Transcription Factor AP-1; Tyrosine	2002
[Pilot study of the effectiveness of combination therapy with reduced dose alteplase and the glycoprotein IIb/IIIa antagonist tirofiban in acute myocardial infarct]. Zeitschrift fur Kardiologie, 2002, Volume: 91, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2002
The TARGET trial: hit or miss? European heart journal, 2002, Volume: 23, Issue:11 Topics: Abciximab; Antibodies, Monoclonal; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Tirofiban; Tyrosine	2002
Decreases in repetitive extrasystole threshold in the conscious pig with myocardial infarct were reversed by tyrosine. Life sciences, 1991, Volume: 49, Issue:6 Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes, Premature; Catecholamines; Female; Heart Rate; Male; Myocardial Infarction; Random Allocation; Swine; Tyrosine; Valine	1991
[Levels of free amino acids in the blood and heart muscle in the human at various periods of myocardial infarct (clinical anatomical parallels)]. Kardiologiia, 1968, Volume: 8, Issue:11 Topics: Alanine; Amino Acids; Arginine; Aspartic Acid; Chromatography; Erythrocytes; Glutamates; Glycine; Histidine; Histocytochemistry; Humans; Isoleucine; Leucine; Lysine; Methods; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Phenylalanine; Serine; Threonine; Time Factors; Tyrosine; Valine	1968